# EDGAR Filing Document

**Accession Number:** 0000756913
**File Stem:** 0001193125-26-012909
**Filing Date:** 2026-1
**Character Count:** 223576
**Document Hash:** 3e20e284414ef20dad09d29e2f5fc412
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-012909.hdr.sgml**: 20260114

**ACCESSION NUMBER**: 0001193125-26-012909

**CONFORMED SUBMISSION TYPE**: N-14

**PUBLIC DOCUMENT COUNT**: 8

**FILED AS OF DATE**: 20260114

**DATE AS OF CHANGE**: 20260114

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JOHN HANCOCK VARIABLE INSURANCE TRUST
- **CENTRAL INDEX KEY:** 0000756913

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** N-14
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-292732
- **FILM NUMBER:** 26533306

**BUSINESS ADDRESS:**
- **STREET 1:** C/O JOHN HANCOCK FUNDS
- **STREET 2:** 200 BERKELEY STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02116
- **BUSINESS PHONE:** 617-663-3000

**MAIL ADDRESS:**
- **STREET 1:** C/O JOHN HANCOCK FUNDS
- **STREET 2:** 200 BERKELEY STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02116

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** JOHN HANCOCK TRUST
- **DATE OF NAME CHANGE:** 20050124

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MANUFACTURERS INVESTMENT TRUST
- **DATE OF NAME CHANGE:** 19971022

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NASL SERIES FUND INC
- **DATE OF NAME CHANGE:** 19881030
**CENTRAL INDEX KEY**: 0000756913

**CENTRAL INDEX KEY**: 0000756913

**CENTRAL INDEX KEY**: 0000756913

**CENTRAL INDEX KEY**: 0000756913

**CENTRAL INDEX KEY**: 0000756913

**CENTRAL INDEX KEY**: 0000756913

## Series and Classes Contracts Data

### Disciplined Value International Trust (Series ID: S000008302)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000022688 | NAV          | JAJJX           |

### American International Trust (Series ID: S000008216)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000022353 | Series III   | JAHPX           |

### Disciplined Value International Trust (Series ID: S000008302)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000022689 | Series I     | JAJHX           |

### American International Trust (Series ID: S000008216)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000022351 | Series I     | JAHLX           |

### Disciplined Value International Trust (Series ID: S000008302)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000022690 | Series II    | JAJIX           |

### American International Trust (Series ID: S000008216)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000022352 | Series II    | JAHMX           |

##### [**Table of Contents**](#toc)
**Registration No. 333-[ ]** 

**As filed with the Securities and Exchange Commission on January 14, 2026** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**FORM N-14** 

**REGISTRATION STATEMENT** 

***UNDER***

***THE SECURITIES ACT OF 1933***

---

| | |
|:---|:---|
| **PRE-EFFECTIVE AMENDMENT NO.** | ☐ |
| **POST-EFFECTIVE AMENDMENT NO.** | ☐ |

---

## JOHN HANCOCK VARIABLE INSURANCE TRUST
**(Exact Name of Registrant as Specified in Charter)** 

**200 Berkeley Street** 

**Boston, Massachusetts 02116** 

**(Address of Principal Executive Offices)** 

**617-663-3000** 

**(Registrant's Area Code and Telephone Number)** 

**Christopher Sechler** 

**Secretary** 

**John Hancock Variable Insurance Trust** 

**200 Berkeley Street** 

**Boston, Massachusetts 02116** 

**(Name and Address of Agent for Service)** 

***Copy to:***

**Mark P. Goshko, Esq.** 

**K&L Gates LLP** 

**One Congress Street** 

**Boston, Massachusetts 02114** 

Title of securities being registered: Shares of beneficial interest ($0.01 par value) of the Registrant.

Approximate date of proposed public offering: As soon as practicable after this Registration Statement becomes effective.

No filing fee is required because an indefinite number of shares of the Registrant have previously been registered pursuant to Section 24(f) under the Investment Company Act of 1940, as amended.

It is proposed that this filing become effective on February 13, 2026 pursuant to Rule 488.

------

##### [**Table of Contents**](#toc)
**PART A** 

**INFORMATION REQUIRED IN THE** 

**PROXY STATEMENT/PROSPECTUS** 

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK VARIABLE INSURANCE TRUST** 

200 Berkeley Street

Boston, Massachusetts 02116

617-663-3000

[February ], 2026

Dear Variable Annuity and Variable Life Contract Owners:

A Special Meeting of Shareholders of American International Trust (the "Fund" or "Acquired Fund"), a series of John Hancock Variable Insurance Trust (the "Trust" or "JHVIT") will be held at 200 Berkeley Street, Boston, Massachusetts 02116, on **April 7, 2026 at 10:00 a.m., Eastern Time** (the "Meeting"). At the Meeting, shareholders of the Acquired Fund, will be asked to consider and approve a proposed Agreement and Plan of Reorganization (the "Plan") providing for the combination of the Acquired Fund into Disciplined Value International Trust (the "Acquiring Fund") (the "Reorganization").

**The Reorganization** 

Under the Plan and with respect to the Reorganization: (i) the Acquiring Fund will acquire all the assets, subject to all the liabilities, of the Acquired Fund in exchange for shares of the Acquiring Fund; (ii) the shares of the Acquiring Fund will be distributed to the shareholders of the Acquired Fund; and (iii) the Acquired Fund will be liquidated and terminated. As a result, each shareholder of the Acquired Fund will become a shareholder of the Acquiring Fund. The total value of all shares of the Acquiring Fund issued in the Reorganization will equal the total value of the net assets of the Acquired Fund. The number of full and fractional shares of the Acquiring Fund received by a shareholder of the Acquired Fund will be equal in value to the value of that shareholder's shares of the Acquired Fund as of the close of regularly scheduled trading on the New York Stock Exchange (the "NYSE") on the closing date of the Reorganization.

In the Reorganization, holders of Series I, Series II, and Series III shares of the Acquired Fund will receive Series I, Series II, and Series NAV shares, respectively, of the Acquiring Fund.

For certain variable life insurance contracts that currently invest in Series I and Series II shares of the Acquired Fund, it is expected that, in connection with the Reorganization, John Hancock Life Insurance Company (U.S.A.) ("John Hancock USA") and John Hancock Life Insurance Company of New York ("John Hancock NY") will replace such Series I and Series II shares with Series NAV shares and Series I shares issued by the Acquiring Fund having an equal value. As a result, affected contract holders will have contract values invested in a class with lower expenses than would have been the case otherwise.

If approved by shareholders of the Acquired Fund, the Reorganization is expected to occur as of the close of regularly scheduled trading on the NYSE on April 24, 2026.

The Board has approved the Reorganization and believes that the Reorganization will benefit shareholders of the Acquired Fund.

The Reorganization is intended to result in a combined Acquiring Fund that has lower net total annual fund operating expenses (both before and after any fee waivers or expense limitations) and stronger prospects for growth and potential opportunities for economies of scale than the Acquired Fund.

The Acquired Fund operates as a feeder fund that invests all of its assets in Class 1 shares of its master fund, International Fund, a series of American Funds Insurance Series (the "Master Fund"). Although the Reorganization will result in an Acquiring Fund with higher effective management fees than those of the Master Fund (which fees American International Trust indirectly bears), each class of shares of the Acquiring Fund to be received in the Reorganization has lower Rule 12b-1 distribution fees than the corresponding classes of shares of the Acquired Fund, which more than offsets the increase in effective management fees.

------

##### [**Table of Contents**](#toc)
The value of your investment will not be affected by the Reorganization. Furthermore, the Reorganization is not expected to be a taxable event for federal income tax purposes for variable annuity or variable life insurance contract owners whose contract values are determined by investment in shares of the Acquired Fund. The expenses of the Reorganization will be borne entirely by the Acquired Fund.

\* \* \*

Although you are not a shareholder of JHVIT, your purchase payments and the earnings on such purchase payments under your variable annuity or variable life insurance contracts issued by John Hancock USA and John Hancock NY are invested in subaccounts of separate accounts established by these companies that are registered under the Investment Company Act of 1940 ("Registered Separate Accounts"), and each subaccount invests in shares of one or more series of JHVIT, including the Acquired Fund and Acquiring Fund. You have the right to instruct these insurance companies, as appropriate, how to vote the shares of the Acquired Fund that are attributable to your contracts as of February 6, 2026, the record date for the Meeting. John Hancock USA and John Hancock NY will vote all shares of the Acquired Fund owned by such companies and attributed to such contracts in proportion to the voting instructions with respect to the fund timely received from owners of contracts participating in separate accounts registered under the 1940 Act.

Enclosed you will find a Notice of Special Meeting of Shareholders, a Proxy Statement/Prospectus for JHVIT, and a Voting Instructions Form. The Proxy Statement/Prospectus provides background information and describes in detail the matters to be voted on at the Meeting.

**The Board has voted in favor of the proposed Reorganization and recommends that you give voting instructions FOR its approval.** 

**In order for shares to be voted at the Meeting based on your instructions, we urge you to read the Proxy Statement/Prospectus and then complete and mail your Voting Instructions Form in the enclosed postage-paid envelope, allowing sufficient time for its receipt by the close of business on April 6. 2026. To give voting instructions by touch-tone telephone or via the Internet, follow the instructions on the Voting Instructions Form.** 

\* \* \*

If you have any questions regarding the Reorganization, please call one of the following numbers:

---

| | |
|:---|:---|
|  For John Hancock USA <br>variable annuity contracts: | (800) 344-1029 |
|  For John Hancock USA <br>variable life contracts: | (800) 732-5543 |
|  For John Hancock NY <br>variable annuity contracts: | (800) 551-2078 |
|  For John Hancock NY <br>variable life contracts: | (800) 732-5543 |

---

---

| |
|:---|
| Sincerely, |
| Christopher Sechler |
| Secretary |
| John Hancock Variable Insurance Trust |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK VARIABLE INSURANCE TRUST** 

200 Berkeley Street

Boston, Massachusetts 02116

617-663-3000

**NOTICE OF SPECIAL MEETING OF SHAREHOLDERS** 

**OF AMERICAN INTERNATIONAL TRUST** 

**To the Shareholders of American International Trust:** 

Notice is hereby given that a special meeting of shareholders (the "Meeting") of American International Trust (the "**Acquired** Fund"), a series of John Hancock Variable Insurance Trust (the "Trust" or "JHVIT"), will be held at 200 Berkeley Street, Boston, Massachusetts 02116, on **April 7, 2026 at 10:00 a.m., Eastern Time**.

Access to the Meeting is limited to variable insurance and annuity contract owners who are authorized to give voting instructions to shareholders and to representatives of the insurance company separate accounts that own shares of the Acquired Fund.

A Proxy Statement/Prospectus providing information about the following proposal to be voted on at the Meeting is included with this notice. The Meeting will be held for the following purpose:

---

| | | |
|:---|:---|:---|
| Proposal: | To approve an Agreement and Plan of Reorganization providing for the reorganization of the Acquired Fund into Disciplined Value International Trust (the "Acquiring Fund"), each a series of the Trust. Under this agreement, the Acquired Fund would transfer all of its assets to the Acquiring Fund in exchange for shares of the Acquiring Fund. These shares would be distributed, as described in the accompanying Proxy Statement/Prospectus, proportionately to you and the other shareholders of the Acquired Fund. The direct costs of the Reorganization will be borne by the Acquired Fund. The Acquiring Fund would also assume substantially all of the Acquired Fund's liabilities. | To approve an Agreement and Plan of Reorganization providing for the reorganization of the Acquired Fund into Disciplined Value International Trust (the "Acquiring Fund"), each a series of the Trust. Under this agreement, the Acquired Fund would transfer all of its assets to the Acquiring Fund in exchange for shares of the Acquiring Fund. These shares would be distributed, as described in the accompanying Proxy Statement/Prospectus, proportionately to you and the other shareholders of the Acquired Fund. The direct costs of the Reorganization will be borne by the Acquired Fund. The Acquiring Fund would also assume substantially all of the Acquired Fund's liabilities. |
|  | **Acquired Fund Outstanding Shares to be Exchanged** | **Acquiring Fund Shares to be Received** |
|  | Series I | Series I |
|  | Series II | Series II |
|  | Series III | Series NAV |

---

Any other business that may properly come before the Meeting.

**The Board of Trustees of JHVIT recommends that shareholders vote "FOR" the Proposal.** 

Each variable insurance and annuity contract owner eligible to give voting instructions and each shareholder of record at the close of business on February 6, 2026 is entitled to receive notice of and to vote at the Meeting and any adjournments thereof.

***Whether or not you expect to attend the Meeting, please complete and return the enclosed proxy card in the accompanying envelope. No postage is necessary if mailed in the United States. If variable insurance and annuity contract owners eligible to give voting instructions and shareholders do not return their proxies in sufficient numbers, it may result in the need for additional shareholder solicitation efforts.***

---

| |
|:---|
| Sincerely yours, |
| Christopher Sechler |
| Secretary |
| John Hancock Variable Insurance Trust |
| [February ], 2026 |
| Boston, Massachusetts |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK VARIABLE INSURANCE TRUST** 

**COMBINED PROXY STATEMENT AND PROSPECTUS** 

**PROXY STATEMENT for** 

**American International Trust (the "Acquired Fund," or "your Fund"),** 

**a series of John Hancock Variable Insurance Trust (the "Trust" or "JHVIT")** 

**PROSPECTUS for** 

**Disciplined Value International Trust (the "Acquiring Fund")** 

**a series of the Trust,** 

**(together with the Acquired Fund, the "Funds," and each a "Fund")** 

The address of each Fund is 200 Berkeley Street, Boston, Massachusetts 02116, 617-663-3000.

This Proxy Statement/Prospectus contains information shareholders should know before voting on the proposed reorganization of the Acquired Fund into the Acquiring Fund (the "Reorganization"). Please read it carefully and retain it for future reference. This Proxy Statement/Prospectus is being mailed on or about [February ], 2026 to shareholders of the Acquired Fund as of February 6, 2025. Please read it carefully and retain it for future reference.

**Where to Get More Information** 

Information in the following documents is incorporated by reference into (and therefore legally part of) this Proxy Statement/Prospectus:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• [The Acquiring Fund Series I, Series II and Series NAV summary prospectus, dated April 28, 2025, as supplemented to date.](http://www.sec.gov/Archives/edgar/data/756913/000119312525097337/d931202d497k.htm)

This summary prospectus is in the same envelope as this Proxy Statement/Prospectus.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• [The JHVIT Prospectus dated April 28, 2025, as supplemented (File Nos. 2-94157 and 811-04146)](http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/756913/000119312525082716/d891604d485bpos.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• [JHVIT's Annual Report for the period ended December 31, 2024 (File No. 811-04146)](http://www.sec.gov/Archives/edgar/data/756913/000168386325001776/f41004d1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• [JHVIT's Semiannual Report for the period ended June 30, 2025 (File No. 811-04146)](http://www.sec.gov/Archives/edgar/data/756913/000168386325007147/f42696d1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• [The Statement of Additional Information of JHVIT dated April 28, 2025, as supplemented (the "JHVIT SAI") (File Nos. 2-94157 and 811-04146)](http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/756913/000119312525082716/d891604d485bpos.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A Statement of Additional Information dated [February   ], 2026 (File No. 333-[___]) relating to this Proxy Statement/Prospectus (the "SAI")

Each of the above referenced documents contains information with respect to both the Acquired Fund and the Acquiring Fund. These documents and additional information about the Funds are on file with the SEC and are available at no charge by writing to us or by calling the appropriate toll-free telephone number below.

Contract holders having any questions regarding the Reorganization should call the appropriate toll free number listed below:

---

| | |
|:---|:---|
| For John Hancock USA variable annuity contracts: | (800) 344-1029 |
| For John Hancock USA variable life contracts: | (800) 827-4546 |
| For John Hancock NY variable annuity contracts: | (800) 551-2078 |
| For John Hancock NY variable life contracts: | (888) 267-7784 |

---

**Shares of the Acquiring Fund are not deposits or obligations of, or guaranteed or endorsed by, any bank or other depository institution. These shares are not federally insured by the Federal Deposit Insurance Corporation, the U.S. Federal Reserve Board, or any other government agency.** 

**Shares of the Acquiring Fund have not been approved or disapproved by the SEC. The SEC has not passed upon the accuracy or adequacy of this Prospectus. Any representation to the contrary is a criminal offense.** 

The date of this Proxy Statement/Prospectus is [February ], 2026.

------

##### [**Table of Contents**](#toc)
**The Reorganization** 

Under the Plan and with respect to the Reorganization: (i) the Acquiring Fund will acquire all the assets, subject to all the liabilities, of the Acquired Fund in exchange for shares of the Acquiring Fund; (ii) the shares of the Acquiring Fund will be distributed to the shareholders of the Acquired Fund; and (iii) the Acquired Fund will liquidate and terminate. As a result, each shareholder of the Acquired Fund will become a shareholder of the Acquiring Fund. The total value of all shares of the Acquiring Fund issued in the Reorganization will equal the total value of the net assets of the Acquired Fund. The number of full and fractional shares of the Acquiring Fund received by a shareholder of the Acquired Fund will be equal in value to the value of that shareholder's shares of the Acquired Fund as of the close of regularly scheduled trading on the New York Stock Exchange (the "NYSE") on the closing date of the Reorganization, which is expected to be on or about April 24, 2026 (the "Exchange Date").

In the Reorganization, holders of Series I, Series II and Series III shares of the Acquired Fund will receive Series I, Series II, and Series NAV shares, respectively, of the Acquiring Fund.

For certain variable life insurance contracts that currently invest in Series I and Series II shares of the Acquired Fund, it is expected that, in connection with the Reorganization, John Hancock Life Insurance Company (U.S.A.) ("John Hancock USA") and John Hancock Life Insurance Company of New York ("John Hancock NY") will replace such Series I and Series II shares with Series NAV shares and Series I shares issued by the Acquiring Fund having an equal value. As a result, affected contract holders will have contract values invested in a class with lower expenses than would have been the case otherwise.

If approved by shareholders of the Acquired Fund, the Reorganization is expected to occur as of the close of regularly scheduled trading on the NYSE on April 24, 2026. All share classes of the Acquired Fund will vote in the aggregate and not by class. The terms and conditions of the Reorganization are more fully described below in this Proxy Statement/Prospectus and in the form of the Plan attached hereto as Appendix A.

**General** 

JHVIT is subject to the informational requirements of the Securities Exchange Act of 1934, as amended, and the Investment Company Act of 1940, as amended (the "1940 Act"), and files reports, proxy materials and other information with the SEC. Such materials also are available on the SEC's EDGAR Database on its website at sec.gov, and copies may be obtained, after paying a duplicating fee, by email request addressed to publicinfo@sec.gov.

------

##### [**Table of Contents**](#toc)
**TABLE OF CONTENTS** 

---

| | |
|:---|:---|
| **[INTRODUCTION](#proxy924532_1)** | **2** |
| **[OVERVIEW OF THE REORGANIZATION](#proxy924532_2)** | **2** |
| **[PROPOSAL APPROVAL OF AGREEMENT AND PLAN OF REORGANIZATION PROVIDING FOR THE REORGANIZATION OF AMERICAN INTERNATIONAL TRUST INTO DISCIPLINED VALUE INTERNATIONAL TRUST](#proxy924532_3)** | **4** |
| **[INFORMATION ABOUT THE REORGANIZATION](#proxy924532_4)** | **15** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [Agreement and Plan of Reorganization](#proxy924532_5) | 15 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [Reasons for the Reorganization](#proxy924532_6) | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [Board Consideration of the Reorganization](#proxy924532_7) | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [Description of the Securities to Be Issued](#proxy924532_8) | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [Other Matters Regarding Certain Contract Holders](#proxy924532_9) | 18 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [Federal Income Tax Consequences](#proxy924532_10) | 18 |
| **[CAPITALIZATION](#proxy924532_11)** | **18** |
| **[ADDITIONAL INFORMATION ABOUT THE FUNDS](#proxy924532_12)** | **21** |
| **[ADDITIONAL INFORMATION ABOUT THE FUNDS](#proxy924532_13)** | **22** |
| **[SHAREHOLDERS AND VOTING INFORMATION](#proxy924532_14)** | **22** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [Shareholders of JHVIT](#proxy924532_15) | 22 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [Voting Procedures](#proxy924532_16) | 22 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [Solicitation of Proxies and Voting Instructions](#proxy924532_17) | 23 |
|  **[OUTSTANDING SHARES AND SHARE OWNERSHIP](#proxy924532_18)** | **24** |
|  **[FINANCIAL STATEMENTS; EXPERTS](#proxy924532_19)** | **24** |
|  **[LEGAL MATTERS](#proxy924532_20)** | **25** |
|  **[OTHER MATTERS](#proxy924532_21)** | **25** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [Appendix A FORM OF AGREEMENT AND PLAN OF REORGANIZATION](#proxy924532_22) | A-1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [Appendix B FINANCIAL HIGHLIGHTS OF THE FUNDS](#proxy924532_23) | B-1 |

---

------

##### [**Table of Contents**](#toc)
**INTRODUCTION** 

This Proxy Statement/Prospectus is furnished in connection with the solicitation by the Board of proxies to be used at the Meeting. The Board has designated February 6, 2026 as the record date for determining shareholders eligible to vote at the Meeting (the "Record Date"). All shareholders of record at the close of business on the Record Date are entitled to one vote for each share (and fractional votes for fractional shares) of beneficial interest of the Acquired Fund held.

**JHVIT.** JHVIT is an open-end investment company registered under the 1940 Act. JHVIT currently offers 50 separate series, including the Acquired and Acquiring Fund. JHVIT does not sell its shares directly to the public but generally only to affiliated insurance companies and their separate accounts as the underlying investment media for variable annuity and variable life insurance contracts ("variable contracts"), certain entities affiliated with the insurance companies, as permitted by applicable law, and other series of JHVIT that operate as funds of funds. Shares of JHVIT also may be sold to unaffiliated insurance companies and their separate accounts and certain qualified pension and retirement plans.

**Investment Management.** John Hancock Variable Trust Advisers LLC ("JHVTA" or the "Advisor") serves as investment advisor to the Acquiring Fund. Pursuant to an Amended and Restated Advisory Agreement with JHVIT on behalf of the Acquiring Fund, dated June 30, 2020, JHVTA is responsible for, among other things, administering the business and affairs of the Acquiring Fund and selecting, contracting with, compensating and monitoring the performance of any investment subadvisor that manages the investment of the assets of the Fund pursuant to subadvisory agreements.

The Acquired Fund does not have an investment advisor and invests solely in a master fund, International Fund, a series of American Funds Insurance Series (the "Master Fund"), which is managed by Capital Research and Management Company ("CRMC"). The address of CRMC is 333 South Hope Street, 55<sup>th</sup> Floor, Los Angeles, California, 90071.

Boston Partners Global Investors, Inc. ("Boston Partners" or "the Subadvisor")) serves as investment subadvisor to the Acquiring Fund. Boston Partners' address is One Beacon Street, 30<sup>th</sup> Floor, Boston, Massachusetts 02108.

JHVTA, CRMC and Boston Partners are registered with the SEC as investment advisors under the Investment Advisers Act of 1940, as amended.

**The Distributor.** John Hancock Distributors, LLC ("JH Distributors") serves as JHVIT's distributor.

The offices of JHVTA and JH Distributors are located at 200 Berkeley Street, Boston, Massachusetts 02116. Their ultimate parent entity is Manulife Financial Corporation ("MFC"), a publicly traded company based in Toronto, Canada. MFC and its subsidiaries operate as "Manulife Financial" in Canada and Asia and principally as "John Hancock" in the United States.

**OVERVIEW OF THE REORGANIZATION** 

**The following is a summary discussion of the form and consequences of, and the reasons for, the Reorganization.** 

At an in-person meeting held December 8-11, 2025, the Board including all the Trustees who are not "interested persons" (as defined in the 1940 Act) of JHVIT, the Advisor, the Subadvisor, or JH Distributors (the "Independent Trustees"), approved the Plan providing for the Reorganization of the Acquired Fund into the Acquiring Fund. The Reorganization contemplates: (i) the transfer of all the assets, subject to all of the liabilities, of the Acquired Fund to the Acquiring Fund in exchange for shares of the Acquiring Fund; (ii) the distribution to shareholders of the Acquired Fund of the shares of the Acquiring Fund; and (iii) the liquidation and termination of the Acquired Fund.

As a result of the Reorganization, shareholders of the Acquired Fund will become shareholders of the Acquiring Fund. In the Reorganization, the Acquiring Fund will issue a number of shares with a total value equal to the total value of the net assets of the Acquired Fund, and each shareholder of the Acquired Fund will receive a number of full and fractional shares of the Acquiring Fund with a total value equal to the total value of that shareholder's shares of the Acquired Fund, as of the close of regularly scheduled trading on the NYSE on the closing date of the Reorganization (the "Exchange Date").

------

##### [**Table of Contents**](#toc)
In the Reorganization, holders of Series I, Series II, and Series III shares of the Acquired Fund will receive Series I, Series II, and Series NAV shares, respectively, of the Acquiring Fund.

For certain variable life insurance contracts that currently invest in Series I and Series II shares of the Acquired Fund, it is expected that, in connection with the Reorganization, John Hancock Life Insurance Company (U.S.A.) ("John Hancock USA") and John Hancock Life Insurance Company of New York ("John Hancock NY") will replace such Series I and Series II shares with Series NAV shares and Series I shares issued by the Acquiring Fund having an equal value. As a result, affected contract holders will have contract values invested in a class with lower expenses than would have been the case otherwise.

The Board has approved the Reorganization and believes that the Reorganization will benefit shareholders of the Acquired Fund.

With respect to the Acquired Fund, the Reorganization is intended to result in a combined Acquiring Fund that has lower net total annual fund operating expenses (both before and after any fee waivers or expense limitations), and stronger prospects for growth and economies of scale than the Acquired Fund. On a *pro forma* basis, each class of the resulting combined Acquiring Fund after the Reorganization is expected to have total operating expenses that are lower than those of the Acquired Fund share classes exchanged in the Reorganization.

The Acquired Fund operates as a feeder fund that invests all of its assets in the Master Fund. Although the Reorganization will result in an Acquiring Fund with higher effective management fees than those of the Master Fund (which fees the Acquired Fund indirectly bears), each class of shares of the Acquiring Fund to be received in the Reorganization has lower Rule 12b-1 distribution fees than the corresponding classes of shares of the Acquired Fund, which more than offsets the increase in effective management fees.

The factors that the Board considered in deciding to approve the Reorganization are discussed below under "Information About the Reorganization — Board Consideration of the Reorganization."

The Reorganization is not expected to be a taxable event for federal income tax purposes for owners of variable contracts whose contract values are determined by investment in shares of the Acquired Fund. See "Information About the Reorganization – Federal Income Tax Consequences."

Immediately preceding the Reorganization, the Acquired Fund may, in certain situations, not comply with its investment policies due to the need to make changes to its portfolio to facilitate the Reorganization. The Reorganization will not result in any material change in the purchase and redemption procedures followed with respect to the distribution of shares.

The projected expenses of the Reorganization (consisting of legal, accounting, printing, and solicitation and proxy tabulation costs) are $198,773, of which $182,626 will be borne by the Acquired Fund (amounting to four basis points and less than $0.01 per share) and $16,147 will be borne by the Acquiring Fund (amounting to less than one basis point and less than $0.01 per share). If the Reorganization is not consummated, these expenses will be paid by JHVTA. Transaction costs are not anticipated to be material in amount and are estimated to not exceed $10,000, which is less than $0.01 per share.

Prior to or concurrent with the Reorganization, the Acquired Fund anticipates that it will sell all of its investments. However, the Acquired Fund reserves the right not to proceed in this manner and may manage its portfolio in anticipation of the Reorganization in a different manner.

------

##### [**Table of Contents**](#toc)
**PROPOSAL** 

**APPROVAL OF AGREEMENT AND PLAN OF REORGANIZATION PROVIDING FOR THE** 

**REORGANIZATION OF AMERICAN INTERNATIONAL TRUST INTO** 

**DISCIPLINED VALUE INTERNATIONAL TRUST** 

**Shareholders of the Acquired Fund are being asked to approve the Plan providing for the Reorganization of the Acquired Fund into the Acquiring Fund. The Funds are compared below.** 

**Comparison of Acquired and Acquiring Fund** 

Both the Acquired Fund and the Acquiring Fund have similar investment objectives and policies, as outlined in the chart below. The following is a summary of the similarities and differences between the funds' investment policies. The Acquired Fund operates as a feeder fund and invests all of its assets in the Master Fund, whereas the Acquiring Fund invests directly in the various investments described below. The Acquired Fund's objective is to seek to provide long-term growth of capital. The Acquiring Fund's investment objective is to seek long-term growth of capital. The Acquired Fund's and the Acquiring Fund's investment policies are similar in that the Acquired Fund (indirectly through the Master Fund) invests primarily in common stocks of companies outside the United States, including in emerging markets, that the Master Fund's advisor believes have the potential for growth and the Acquiring Fund invests at last 80% of its assets in a portfolio of equity and equity-related securities issued by non-U.S. companies of any capitalization size. The funds differ in that the Acquired Fund considers environmental, social, and/or governance factors alongside other relevant factors in its investment process and the Acquiring Fund does not.

**SUMMARY COMPARISONS OF ACQUIRED FUND TO ACQUIRING FUND** 

---

| | |
|:---|:---|
| **American International Trust <br>(Acquired Fund)** | **Disciplined Value International Trust <br>(Acquiring Fund)** |
| <u>*Approximate Net Assets of Each Fund (as of June 30, 2025):*</u> | <u>*Approximate Net Assets of Each Fund (as of June 30, 2025):*</u> |
| $370 million | $302 million |
| <u>*Investment Advisor:*</u> | <u>*Investment Advisor:*</u> |
| The fund is a feeder fund that invests all of its<br> investable assets in International Fund, managed by<br> Capital Research and Management Company | John Hancock Variable Trust Advisers LLC |
| <u>*Investment Subadvisor:*</u> | <u>*Investment Subadvisor:*</u> |
| Not Applicable | Boston Partners Global Investors, Inc. |

---

------

##### [**Table of Contents**](#toc)

---

| | |
|:---|:---|
| **American International Trust <br>(Acquired Fund)** | **Disciplined Value International Trust <br>(Acquiring Fund)** |
| *<u>Portfolio Managers</u>* | *<u>Portfolio Managers</u>* |
| <u>Portfolio Managers of the Master Fund</u><br>*Nicholas J. Grace*. Partner — Capital Research Global Investors; investment professional for 44 years in total; 42 years with CRMC or affiliate.<br>*Bradford F. Freer.* Partner — Capital World Investors; investment professional for 27 years in total; 23 years with CRMC or affiliate.<br>*Carl M. Kawaja.* Partner — Capital Research Global Investors; investment professional for 23 years, all with CRMC or affiliate.<br>*Robert H. Neithart.* Vice President — Capital Fixed Income Investors, Capital Research and Management Company; investment professional for 26 years in total; 14 years with CRMC or affiliate. | *Christopher Hart, CFA*. Portfolio Manager. Mr. Hart joined Boston Partners in 2002 and has managed the fund since 2020.<br>*Joshua Jones, CFA*. Portfolio Manager. Mr. Jones joined Boston Partners in 20026 and has managed the fund since 2020.<br>*Soyoun Song*. Portfolio Manager. Mr. Song joined Boston Partners in 2019 and has managed the fund since 2024. |
| <u>*Investment Objectives:*</u> | <u>*Investment Objectives:*</u> |
| To seek to provide long-term growth of capital. | To seek long-term growth of capital. |
| *<u>Principal Investment Strategies:</u>* | *<u>Principal Investment Strategies:</u>* |
| The fund invests all of its assets in Class 1 shares of its master fund, the International Fund, a series of American Funds Insurance Series. The International Fund invests primarily in common stocks of companies domiciled outside the United States, including companies domiciled in emerging markets, that the advisor believes have the potential for growth.<br>The master fund may invest in other funds managed by the investment adviser or its affiliates to more effectively invest in a diversified set of securities in a specific asset class such as money market instruments, bonds and other securities ("Central Funds"). Shares of Central Funds are only offered for purchase to the master fund's investment advisor and its affiliates and other funds, investment vehicles and accounts managed by the master fund's investment advisor and its affiliates. When investing in Central Funds, the master fund bears its proportionate share of the expenses of the Central Funds in which it invests but does not bear additional management fees through its investment in such Central Funds. The investment results of the portion of the master fund's assets invested in the Central Funds will be based upon the investment results of the Central Funds. | The Board of Trustees can change the fund's investment objective and strategies without shareholder approval.<br>The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in a portfolio of equity and equity-related securities issued by non-U.S. companies of any capitalization size. The fund may invest in all types of equity and equity-related securities, including, without limitation, exchange-traded and over-the-counter common and preferred stocks, warrants, options, rights, convertible securities, sponsored and unsponsored depositary receipts and shares, trust certificates, participatory notes, limited partnership interests, shares of other investment companies (including exchange-traded funds (ETFs)), real estate investment trusts (REITs), and equity participations. An equity participation is a type of loan that gives the lender a portion of equity ownership in a property, in addition to principal and interest payments. A convertible security is a bond, debenture, note, preferred stock, or other security that may be converted into or exchanged for a prescribed amount of common stock of the same or a different issuer within a particular period of time at a specified price or formula. |

---

------

##### [**Table of Contents**](#toc)

---

| | |
|:---|:---|
| **American International Trust <br>(Acquired Fund)** | **Disciplined Value International Trust <br>(Acquiring Fund)** |
| The manager considers environmental, social, and/or governance (ESG) factors, alongside other relevant factors, as part of its investment process. ESG factors may include, but are not limited to, matters regarding board diversity, climate change policies, and supply chain and human rights policies. The ESG characteristics utilized in the fund's investment process may change over time and one or more characteristics may not be relevant with respect to all issuers that are eligible fund investments. Because ESG factors are considered alongside other relevant factors, the manager may determine that an investment is appropriate notwithstanding its relative ESG characteristics. | The fund defines non-U.S. companies as companies: (i) that are organized under the laws of a foreign country; (ii) whose principal trading market is in a foreign country; or (iii) that have a majority of their assets, or that derive a significant portion of their revenue or profits, from businesses, investments, or sales outside of the United States. The fund primarily will be invested in issuers located in countries with developed securities markets, but may also invest in issuers located in emerging and frontier markets.<br>The fund may invest in securities denominated in the currencies of a variety of developed, emerging and frontier market countries.<br>The fund generally invests in the equity securities of issuers believed by the manager to be undervalued in the marketplace, focusing on issuers that combine attractive valuations with catalysts for change. The manager applies a bottom-up stock selection process (i.e., one that focuses primarily on issuer specific factors) in managing the fund, using a combination of fundamental and quantitative analysis. In selecting investments for the fund, the manager considers various factors, such as price-to-book value, price-to-sales and earnings ratios, dividend yields, strength of management, and cash flow to identify securities that are trading at a price that appears to be lower than the issuer's inherent value.<br>The fund may (but is not required to) invest in derivatives, including put and call options, futures, forward contracts, and swaps, in lieu of investing directly in a security, currency or instrument, for hedging and nonhedging purposes, including reducing risk, obtaining efficient market exposure, and/or enhancing investment returns.<br>The fund may invest up to 15% of its net assets in illiquid securities, including securities that are illiquid by virtue of the absence of a readily available market or legal or contractual restrictions on resale.<br>The fund may participate as a purchaser in Initial Public Offerings (IPOs). An IPO is a company's first offering of stock to the public. The fund may also seek to increase its income by lending portfolio securities. |

---

------

##### [**Table of Contents**](#toc)

---

| | |
|:---|:---|
| **American International Trust <br>(Acquired Fund)** | **Disciplined Value International Trust <br>(Acquiring Fund)** |
|  | The manager will sell a stock when it no longer meets one or more investment criteria, either through obtaining target value or due to an adverse change in fundamentals or business momentum. Each holding has a target valuation established at purchase, which the manager constantly monitors and adjusts as appropriate.<br>The fund may invest in cash or money market instruments for the purpose of meeting redemption requests or making other anticipated cash payments. |
| *<u>Temporary Defensive Investing</u>* | *<u>Temporary Defensive Investing</u>* |
| During unusual or unsettled market conditions, for purposes of meeting redemption requests, or pending investment of its assets, or in carrying out changes to the fund's subadvisor or investment process, a fund generally may invest all or a portion of its assets in cash and securities that are highly liquid, including: (a) high quality money market instruments, such as short-term U.S. government obligations, commercial paper, repurchase agreements or other cash equivalents; and (b) money market funds. In the case of funds investing extensively in foreign securities, these investments may be denominated in either U.S. dollars or foreign currencies and may include debt of foreign corporations, governments and supranational organizations. To the extent a fund is in a defensive position, its ability to achieve its investment objective will be limited. | During unusual or unsettled market conditions, for purposes of meeting redemption requests, or pending investment of its assets, or in carrying out changes to the fund's subadvisor or investment process, a fund generally may invest all or a portion of its assets in cash and securities that are highly liquid, including: (a) high quality money market instruments, such as short-term U.S. government obligations, commercial paper, repurchase agreements or other cash equivalents; and (b) money market funds. In the case of funds investing extensively in foreign securities, these investments may be denominated in either U.S. dollars or foreign currencies and may include debt of foreign corporations, governments and supranational organizations. To the extent a fund is in a defensive position, its ability to achieve its investment objective will be limited. |

---

------

##### [**Table of Contents**](#toc)
**Comparison of, and Effect on, Fund Operating Expenses** 

The operating expenses of each Fund for the twelve-month period ended June 30, 2025 (including *pro forma* expenses showing the effect of the Reorganization) are set forth below. On a *pro forma* basis, each class of shares of the resulting combined Acquiring Fund after the Reorganization is expected to have total operating expenses (prior to any fee waivers or expense limitations) that are lower than those of the respective Acquired Fund share classes exchanged in the Reorganization.

The expense ratios and examples below do not reflect the fees and expenses of any variable contract that may use JHVIT as its underlying investment option. If such fees and expenses had been reflected, the expense ratios would be higher.

In the Reorganization, holders of Series I, Series II, and Series III shares of the Acquired Fund will receive Series I, Series II, and Series NAV shares, respectively, of the Acquiring Fund.

For certain variable life insurance contracts that currently invest in Series I and Series II shares of the Acquired Fund, it is expected that, in connection with the Reorganization, John Hancock Life Insurance Company (U.S.A.) ("John Hancock USA") and John Hancock Life Insurance Company of New York ("John Hancock NY") will replace such Series I and Series II shares with Series NAV shares and Series I shares issued by the Acquiring Fund having an equal value. As a result, affected contract holders will have contract values invested in a class with lower expenses than would have been the case otherwise.

**Annual Fund Operating Expenses (12-month period ended 6/30/25)** 

(expenses that you pay each year as a percentage of the value of your investment)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Fund/Share** | **Management<br>fees** | **Distribution<br>and service<br>(Rule 12b-1)<br>fees** | **Other<br>expenses** | **Total<br>annual<br>fund<br>operating<br>expenses** | **Contractual<br>expense<br>reimbursement<sup>1</sup>** | **Total annual<br>fund operating<br>expenses after<br>expense<br>reimbursements** |
| **(1) American International Trust**<br> (Acquired Fund) |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Series I | 0.48%<sup>2</sup> | 0.60% | 0.09%<sup>2</sup> | 1.17%<sup>2</sup> | (0.01)% | 1.16% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Series II | 0.48%<sup>2</sup> | 0.75% | 0.09%<sup>2</sup> | 1.32%<sup>2</sup> | (0.01)% | 1.31% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Series III | 0.48%<sup>2</sup> | 0.25% | 0.09%<sup>2</sup> | 0.82%<sup>2</sup> | (0.01)% | 0.81% |
| **(2) Disciplined Value International Trust** <br>(Acquiring Fund) |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Series I | 0.68% | 0.05% | 0.12% | 0.85% | (0.01)% | 0.84% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Series II | 0.68% | 0.25% | 0.12% | 1.05% | (0.01)% | 1.04% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Series NAV | 0.68% | 0.00% | 0.12% | 0.80% | (0.01)% | 0.79% |
| **(3) Disciplined Value International Trust** <br>(Acquiring Fund) <br>(*Pro forma* combining (1) and (2)) |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Series I | 0.67% | 0.05% | 0.10% | 0.82% | (0.01)% | 0.81% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Series II | 0.67% | 0.25% | 0.10% | 1.02% | (0.01)% | 1.01% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Series NAV | 0.67% | 0.00% | 0.10% | 0.77% | (0.01)% | 0.76% |

---

1. The advisor contractually agrees to waive a portion of its management fee and/or reimburse expenses for the
fund and certain other John Hancock funds according to an asset level breakpoint schedule that is based on the aggregate net assets of all the funds participating in the waiver or reimbursement, including the fund (the participating portfolios).
This waiver equals, on an annualized basis, 0.0100% of that portion of the aggregate net assets of all the participating portfolios that exceeds $75 billion but is less than or equal to $125 billion; 0.0125% of that portion of the
aggregate net assets of all the participating portfolios that exceeds $125 billion but is less than or equal to $150 billion; 0.0150% of that portion of the aggregate net assets of all the participating portfolios that exceeds
$150 billion but is less than or equal to $175 billion; 0.0175% of that portion of the aggregate net assets of all the participating portfolios that exceeds $175

------

##### [**Table of Contents**](#toc)
billion but is less than or equal to $200 billion; 0.0200% of that portion of the aggregate net assets of all the participating portfolios that exceeds $200 billion but is less than or equal to $225 billion; and 0.0225% of that portion of the aggregate net assets of all the participating portfolios that exceeds $225 billion. The amount of the reimbursement is calculated daily and allocated among all the participating portfolios in proportion to the daily net assets of each participating portfolio. During its most recent fiscal year, the fund's reimbursement amounted to 0.01% of the fund's average daily net assets. This agreement expires on July 31, 2027, unless renewed by mutual agreement of the fund and the advisor based upon a determination that this is appropriate under the circumstances at that time.

2. The table reflects the combined fees of the feeder fund and the master fund.

**Examples:** The examples are intended to help you compare the costs of investing in the Acquired and Acquiring Fund. The examples assume that $10,000 is invested in the particular Fund for the periods indicated and then all shares are redeemed at the end of those periods. The examples also assume that the investment has a 5% return each year and that each Fund's operating expenses remain the same. The expense examples do not reflect fees and expenses of any variable insurance contract that may use a Fund as its underlying investment option and would be higher if they did. Although your actual costs may be higher or lower, based on these assumptions your costs would be:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Fund/Share Class** |  | **One Year** | **Three Years** | **Five Years** | **Ten Years** |
| **(1) American International Trust** <br>(Acquired Fund) | Series I | $118 | $371 | $643 | $1419 |
|  | Series II | $133 | $417 | $723 | $1589 |
|  | Series III | $83 | $261 | $454 | $1013 |
| **(2) Disciplined Value International Trust**<br> (Acquiring Fund) | Series I | $86 | $270 | $470 | $1048 |
|  | Series II | $106 | $333 | $578 | $1282 |
|  | Series NAV | $81 | $254 | $443 | $989 |
| **(3) Disciplined Value International Trust**<br> (Acquiring Fund) <br>*(Pro forma combining (1) and (2))* | Series I | $83 | $261 | $454 | $1013 |
|  | Series II | $103 | $324 | $562 | $1247 |
|  | Series NAV | $78 | $245 | $427 | $953 |

---

**Portfolio Turnover.** The Acquired Fund, which operates as a feeder fund, does not pay transaction costs, such as commissions, when it buys and sells shares of the Master Fund. The Master Fund does pay transaction costs when it turns over its portfolio, and a higher portfolio turnover rate may indicate higher transaction costs. These costs, which are not reflected in annual fund operating expenses or in the example, affect the performance of the Master Fund and of the Acquired Fund. During the fiscal period ended June 30, 2025, the Master Fund's portfolio turnover rate was 42% of the average value of its portfolio.

The Acquiring Fund pays transaction costs, such as commissions, when it buys and sells securities (or "turns over" its portfolio). A higher portfolio turnover rate may indicate higher transaction costs. These costs, which are not reflected in annual fund operating expenses or in the example, affect the Acquiring Fund's performance. During the fiscal period ended June 30, 2025, the portfolio turnover rate for the Acquiring Fund was 36% of the average value of its portfolio.

**Distribution, Purchase and Redemption Procedures and Exchange Rights.** The distribution, purchase and redemption procedures of each Fund, and the exchange rights of the corresponding classes of each Fund, are the same.

**Comparison of Investment Risks** 

The net asset value ("NAV") of each Fund's shares will go up and down, meaning that you could lose money on your investment in either Fund. Because the Funds have similar investment objectives and principal investment strategies, as described above, they have similar risks. The principal risks of investing in the Funds are:

------

##### [**Table of Contents**](#toc)
<u>Principal Risks Applicable to Both Funds (listed in alphabetical order)</u> 

**Economic and market events risk.** Events in the U.S. and global financial markets, including actions taken by the U.S. Federal Reserve or foreign central banks to stimulate or stabilize economic growth, may at times result in unusually high market volatility, which could negatively impact performance. Reduced liquidity in credit and fixed-income markets could adversely affect issuers worldwide. Banks and financial services companies could suffer losses if interest rates rise or economic conditions deteriorate.

**Equity securities risk.** The price of equity securities may decline due to changes in a company's financial condition or overall market conditions. (Acquired Fund only: Growth company securities fluctuate more in price than other securities because of the greater emphasis on earnings expectations.) (Acquiring Fund only: Securities the manager believes are undervalued may never realize their full potential value, and in certain markets value stocks may underperform the market as a whole.)

**Foreign securities risk.** Less information may be publicly available regarding foreign issuers. Foreign securities may be subject to foreign taxes and may be more volatile than U.S. securities. Currency fluctuations and political and economic developments may adversely impact the value of foreign securities. The risks of investing in foreign securities are magnified in emerging markets. (Acquiring Fund only: Depositary receipts are subject to most of the risks associated with investing in foreign securities directly because the value of a depositary receipt is dependent upon the market price of the underlying foreign equity security. Depositary receipts are also subject to liquidity risk.)

**Investment company securities risk.** Fund shareholders indirectly bear their proportionate shares of the expenses of any investment company in which the fund invests. The total return on such investments will be reduced by the operating expenses and fees of such other investment companies, including advisory fees.

**Large company risk.** Larger companies may grow more slowly than smaller companies or be slower to respond to business developments. Large-capitalization securities may underperform the market as a whole.

**Liquidity risk.** The extent (if at all) to which a security may be sold without negatively impacting its market value may be impaired by reduced market activity or participation, legal restrictions, or other economic and market impediments.

**Operational and cybersecurity risk.** Cybersecurity breaches may allow an unauthorized party to gain access to fund assets, customer data, or proprietary information, or cause a fund or its service providers to suffer data corruption or lose operational functionality. Similar incidents affecting issuers of a fund's securities may negatively impact performance. Operational risk may arise from human error, error by third parties, communication errors, or technology failures, among other causes.

**Small and mid-sized company risk.** Small and mid-sized companies are generally less established and may be more volatile than larger companies. Small capitalization securities may underperform the market as a whole.

**<u>Principal Risks Applicable only to the Acquired Fund</u>**

**ESG integration risk.** The manager considers ESG factors that it deems relevant or additive, along with other material factors and analysis, when managing the fund. ESG factors may include, but are not limited to, matters regarding board diversity, climate change policies, and supply chain and human rights policies. The manager may consider these ESG factors on all or a meaningful portion of the fund's investments. Incorporating ESG criteria and making investment decisions based on certain ESG characteristics, as determined by the manager, carries the risk that the fund may perform differently, including underperforming, fund that do not utilize ESG criteria, or fund that utilize different ESG criteria.

------

##### [**Table of Contents**](#toc)
**<u>Principal Risks Applicable only to the Acquiring Fund</u>**

**Cash and cash equivalents risk.** Under certain market conditions, such as during a rising stock market, rising interest rate or rising credit spread markets, the use of cash and/or cash equivalents, including money market instruments, could have a negative effect on the fund's ability to achieve its investment objective and may negatively impact the fund's performance.

**Credit and counterparty risk.** The counterparty to an over-the-counter derivatives contract or a borrower of fund securities may not make timely payments or otherwise honor its obligations.

**Exchange-traded funds (ETFs) risk.** The risks of owning shares of an ETF include the risks of owning the underlying securities the ETF holds. Lack of liquidity in an ETF could result in the ETF being more volatile than its underlying securities. An ETF's shares could trade at a significant premium or discount to its net asset value (NAV). A fund bears ETF fees and expenses indirectly.

**Frontier-market risk.** Frontier-market countries generally have smaller economies and less-developed capital markets and political systems than traditional emerging-market countries, which magnifies emerging-market risks.

**Hedging, derivatives, and other strategic transactions risk.** Hedging, derivatives, and other strategic transactions may increase a fund's volatility and could produce disproportionate losses, potentially more than the fund's principal investment. Risks of these transactions are different from and possibly greater than risks of investing directly in securities and other traditional instruments. Under certain market conditions, derivatives could become harder to value or sell and may become subject to liquidity risk (i.e., the inability to enter into closing transactions). Derivatives and other strategic transactions that the fund intends to utilize include: foreign currency forward contracts, futures contracts, swaps, equity-linked notes (equity-linked notes generally reflect the risks associated with their underlying securities, depend on the credit of the note's issuer, may be privately placed, and may have a limited secondary market), and options. Foreign currency forward contracts, futures contracts, and options generally are subject to counterparty risk. In addition, swaps may be subject to interest rate and settlement risk, and the risk of default of the underlying reference obligation. Derivatives associated with foreign currency transactions are subject to currency risk.

**Illiquid and restricted securities risk.** Illiquid and restricted securities may be difficult to value and may involve greater risks than liquid securities. Illiquidity may have an adverse impact on a particular security's market price and the fund's ability to sell the security.

**Initial public offerings (IPOs) risk.** IPO share prices are frequently volatile and may significantly impact fund performance.

**Participatory notes risk.** Participatory notes (p-notes) represent interests in securities listed on certain foreign exchanges. Due to transaction costs and other expenses, p-notes will not replicate exactly the performance of their underlying securities. P-notes are general unsecured contractual obligations of the financial institutions issuing the notes and are subject to liquidity risk and a high degree of counterparty risk.

**Preferred and convertible securities risk.** Preferred stock dividends are payable only if declared by the issuer's board. Preferred stock may be subject to redemption provisions. The market values of convertible securities tend to fall as interest rates rise and rise as interest rates fall. Convertible preferred stock's value can depend heavily upon the underlying common stock's value.

**Real estate investment trust (REIT) risk.** REITs, pooled investment vehicles that typically invest in real estate directly or in loans collateralized by real estate, carry risks associated with owning real estate, including the potential for a decline in value due to economic or market conditions.

**Value investment style risk.** Value securities may underperform the market as a whole, which may cause value-oriented funds to underperform equity funds with other investment strategies. Securities the manager believes are undervalued may never perform as expected.

------

##### [**Table of Contents**](#toc)
**Warrants risk.** The prices of warrants may not precisely reflect the prices of their underlying securities. Warrant holders do not receive dividends or have voting or credit rights. A warrant ceases to have value if not exercised prior to its expiration date.

**Investment Management Fees/Subadvisory Arrangements** 

Based on information for the twelve-month period ended June 30, 2025, the effective advisory fee rate charged to the Acquiring Fund, is higher than the advisory fee charged to the Master Fund, in which the Acquired Fund, invests,

As a feeder fund, the Acquired Fund does not have an advisor or subadvisor, and accordingly, does not directly pay any management fees. However, the Master Fund in which the Acquired Fund invests all of its assets has an advisor and pays management fees that are borne indirectly by the feeder funds, including the Acquired Fund.

The Acquiring Fund pays JHVTA a management fee that is accrued and paid daily. The advisory fee for the Acquiring Fund is determined based on the application of the annual percentage rates for the Fund to the "Aggregate Net Assets" of the Fund. Aggregate Net Assets of the Acquiring Fund include the net assets of the Fund and the net assets of one or more other John Hancock Fund Complex funds (or portions thereof) stated below that have the same subadvisor as the Fund. If the Acquiring Fund and such other fund(s) (or portions thereof) cease to have the same subadvisor, their assets will no longer be aggregated for purposes of determining the applicable annual fee rate for the Fund.

---

| | |
|:---|:---|
| **American International Trust (Acquired Fund)(paid by the Master Fund)** | **Disciplined Value International Trust (Acquiring Fund)** |
| 0.478% — first $15.0 billion of net assets; plus<br> 0.45% — net assets from $15.0 billion to $17.0 billion; plus<br> 0.44% — net assets from $17.0 billion to $21.0 billion; plus<br> 0.43% — net assets in excess of $21.0 billion. | 0.710% — first $500 million;<br> 0.690% — next $500 million;<br> 0.680% — next $1 billion;<br> 0.670% — next $1 billion;<br> 0.660% — next $2 billion; and<br> 0.650% — excess over $5 billion.<sup>†</sup><br>*<sup>†</sup> The fee schedule above became effective on December 12, 2024.* |
|  | Aggregate net assets are the net assets of the portfolio, Manulife Boston Partners International Equity Fund, Disciplined Value International Fund, a series of John Hancock Investment Trust, MLI Pension Plus Growth Fund, Manulife Balanced Fund, Manulife MIM Diversified Fund, Manulife Diversified Tri-Plan Fund, Manulife Aggressive Asset Allocation Fund, Manulife Balanced Asset Allocation Fund, Manulife Growth Asset Allocation Fund, Manulife Moderate Asset Allocation Fund and Manulife Retirement Date 2025, 2030, 2035, 2040, 2045, 2050, 2055, 2060 and 2065 Funds. |

---

During the twelve-month period ended June 30, 2025, the Master Fund in which the Acquired Fund invests paid an advisory fee of 0.48% to its advisor and the Acquiring Fund paid an effective advisory fee of 0.68%.

Boston Partners serves as the subadvisor to the Acquiring Fund. For its services, Boston Partners receives a subadvisory fee. The subadvisory fee with respect to the Acquiring Fund is paid by JHVTA and is not an additional charge to the Fund.

\* \* \*

------

##### [**Table of Contents**](#toc)
A discussion of the basis of the Board's approval of the continuation of the advisory and subadvisory agreements for the Acquiring Fund at the June 24-26, 2025 Board meeting is available in JHVIT's Semiannual Report to Shareholders for the six-month period ended June 30, 2025.

**Performance** 

The following information provides some indication of the risks of investing in the Funds by showing changes in performance from year to year and by showing how average annual returns for specified periods compare with those of a broad-based securities market index. The Acquiring Fund underperformed the Acquired Fund for the one-year period ended December 31, 2024, but outperformed the Acquired Fund for the five-year and ten-year periods ended December 31, 2024.

The calendar year total returns for each Fund represent the returns for that fund's oldest share class.

Unless all share classes shown in the average annual total returns table have the same inception date, performance shown for periods prior to the inception date of a class is the performance of the fund's oldest share class. For American International Trust, the performance of the fund's oldest share class, for periods prior to its inception, is the performance of the Master Fund share class in which the fund invests, adjusted to reflect the expenses of the fund's oldest class. This pre-inception performance, with respect to any other share class of the fund, has not been adjusted to reflect the Rule 12b-1 fees of that class. As a result, the pre-inception performance shown for a share class other than the oldest share class may be higher or lower than it would be if adjusted to reflect the Rule 12b-1 fees of the class.

The performance information below does not reflect fees and expenses of any variable insurance contract that may use JHVIT as its underlying investment medium. If such fees and expenses had been reflected, performance would be lower.

**The past performance of a fund is not necessarily an indication of how it will perform in the future.** 

**American International Trust** 

(Acquired Fund)

**Calendar year total returns for Series II Shares through December 31, 2024 (%)**![LOGO](g924532snap1.jpg)

---

| | |
|:---|:---|
| Best Quarter: | Q4 2020, 21.55% |
| Worst Quarter: | Q1 2020, -24.67% |

---

Year-to-date total return: the Acquired Fund's total return for the most recent calendar year quarter ended September 30, 2025, was 21.14%.

------

##### [**Table of Contents**](#toc)
**Disciplined Value International Trust**

(Acquiring Fund)

**Calendar year total returns for Series I Shares through December 31, 2024 (%)**![LOGO](g924532snap2.jpg)

---

| | |
|:---|:---|
|  Best Quarter: | Q4 2022, 20.55% |
|  Worst Quarter: | Q1 2020, -28.10% |

---

Year-to-date total return: the Acquiring Fund's total return for the most recent calendar year quarter ended September 30, 2025, was 34.52%.

**Average Annual Total Returns (%) — as of 12/31/2024** 

**American International Trust**

(Acquired Fund)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **1 Year** | **1 Year** | **5 Year** | **5 Year** | **10 Year** | **10 Year** |
|  Series I |  | 2.79 |  | 0.85 |  | 3.63 |
|  Series II |  | 2.61 |  | 0.72 |  | 3.49 |
|  Series III |  | 3.10 |  | 1.19 |  | 3.98 |
|  MSCI ACWI ex USA Index (reflects no deduction for fees, expenses, or taxes, except foreign withholding taxes on dividends) |  | 5.53 |  | 4.10 |  | 4.80 |

---

**Disciplined Value International Trust** 

(Acquiring Fund)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **1 Year** | **1 Year** | **5 Year** | **5 Year** | **10 Year** | **10 Year** |
|  Series I |  | -0.38 |  | 5.85 |  | 4.39 |
|  Series II |  | -0.56 |  | 5.64 |  | 4.19 |
|  Series NAV |  | -0.35 |  | 5.89 |  | 4.45 |
|  MSCI EAFE Index (reflects no deduction for fees, expenses, or taxes, except foreign withholding taxes on dividends) |  | 3.82 |  | 4.73 |  | 5.20 |

---

\* \* \*

------

##### [**Table of Contents**](#toc)
**INFORMATION ABOUT THE REORGANIZATION** 

**Agreement and Plan of Reorganization** 

The following summary of the Plan is qualified in its entirety by reference to the form of the Plan attached to this Proxy Statement/Prospectus as Appendix A. The Plan provides, with respect to the Reorganization, that the Acquiring Fund will acquire all the assets, subject to all the liabilities, of the Acquired Fund in exchange for shares of the Acquiring Fund. Subject to the satisfaction of the conditions described below, such acquisition will take place as of the close of regularly scheduled trading on the NYSE on April 24, 2026 or on such later date as may be determined by JHVIT (the "Exchange Date"). The net asset value per share of each class of shares of the Acquired and Acquiring Fund will be determined by dividing the fund's assets, less liabilities, attributable to that share class, by the total number of outstanding shares of that class. The assets of each Fund will be valued in accordance with the valuation practices of the Acquiring Fund.

The number of full and fractional shares of the Acquiring Fund received by a shareholder of the Acquired Fund will be equal in value to the value of that shareholder's full and fractional shares of the Acquired Fund as of the close of regularly scheduled trading on the NYSE on the Exchange Date (the "Effective Time"). The Acquired Fund will liquidate and distribute pro rata to its shareholders of record as of the Effective Time the shares of the Acquiring Fund received by the Acquired Fund in the Reorganization.

In the Reorganization, holders of Series I, Series II, and Series III shares of the Acquired Fund will receive Series I, Series II, and Series NAV shares, respectively, of the Acquiring Fund.

For certain variable life insurance contracts that currently invest in Series I and Series II shares of the Acquired Fund, it is expected that, in connection with the Reorganization, John Hancock Life Insurance Company (U.S.A.) ("John Hancock USA") and John Hancock Life Insurance Company of New York ("John Hancock NY") will replace such Series I and Series II shares with Series NAV shares and Series I shares issued by the Acquiring Fund having an equal value. As a result, affected contract holders will have contract values invested in a class with lower expenses than would have been the case otherwise.

The liquidation and distribution of the assets of the Acquired Fund will be accomplished by the establishment of accounts on the share records of the Acquiring Fund in the names of the shareholders of the Acquired Fund, each account representing the respective pro rata number of shares of the Acquiring Fund due the shareholder. After such distribution, JHVIT will take all necessary steps under Massachusetts law, JHVIT's Agreement and Declaration of Trust (the "Declaration of Trust"), and any other applicable law to effect a complete dissolution of the Acquired Fund.

The consummation of the Reorganization is subject to the conditions set forth in the Plan, including that the affirmative vote of the holders of at least a Majority of the Outstanding Voting Securities (as defined under "Voting Procedures" below) of the Acquired Fund entitled to vote approve the Reorganization. With respect to the Reorganization, the Plan may be terminated and the Reorganization abandoned at any time prior to the Effective Time, before or after approval by the shareholders of the Acquired Fund, by JHVIT on behalf of either or both of the Acquired and Acquiring Fund if the Board or the officers of JHVIT determine that proceeding with the Reorganization is not in the best interests of either or both funds or their respective shareholders or contract owners. The Plan provides that JHVIT, on behalf of the Acquired or Acquiring Fund, may waive compliance with any of the covenants or conditions made therein for the benefit of that fund, except for certain conditions regarding the receipt of regulatory approvals.

The projected expenses of the Reorganization (consisting of legal, accounting, printing, and solicitation and proxy tabulation costs) are $198,773, of which $182,626 will be borne by the Acquired Fund (amounting to four basis points and less than $0.01 per share) and $16,147 will be borne by the Acquiring Fund (amounting to less than one basis point and less than $0.01 per share). If the Reorganization is not consummated, these expenses will be paid by JHVTA. Transaction costs are not anticipated to be material in amount and are estimated to not exceed $10,000, which is less than $0.01 per share.

If the Plan is not approved by the shareholders of the Acquired Fund or is not consummated for any other reason, the Board will consider other possible courses of action for the Fund.

**The Board recommends that shareholders approve the Plan under the Proposal.** 

------

##### [**Table of Contents**](#toc)
**Reasons for the Reorganization** 

The Board has approved the Reorganization and believes that it will benefit shareholders of the Acquired Fund. The Reorganization is intended to result in an Acquiring Fund that has the potential to achieve a more consistent long-term performance record and stronger prospects for growth and potential opportunities for economies of scale than would be the case for the Acquired Fund.

Based on information for the fiscal year ended December 31, 2024, although the net effective management fee rate charged to the Acquiring Fund would have been higher than the advisory charged to the Master Fund (and borne indirectly by the Acquired Fund), the overall expenses of each class of the Acquiring Fund's shares are lower than the corresponding class of shares of the Acquired Fund due to lower Rule 12b-1 distribution fees borne by the Acquiring Fund.

Series I, Series II, and Series NAV shares of the Acquiring Fund have lower expense ratios (before and after the application of any contractual expense waivers) than those of Series I, Series II, and Series III, respectively, of the Acquired Fund. On a *pro forma* basis, each class of the resulting combined Acquiring Fund after the Reorganization is expected to have total operating expenses (before or after the application of any contractual expense waivers) that are lower than those of the Acquired Fund share classes exchanged in the Reorganization.

**Board Consideration of the Reorganization** 

The Board, including the Independent Trustees, considered the Reorganization at its in-person meeting held on December 8-11, 2025, and reviewed information and materials regarding the Reorganization presented or prepared by, among others, the Advisor. In its review of the Reorganization, the Board was assisted by legal counsel, and the Independent Trustees were also assisted by independent legal counsel. In reaching its decision at the December 8-11, 2025 meeting to recommend approval of the Reorganization, the Board concluded that the participation of the Acquired Fund in the Reorganization is in the best interests of the Fund, as well as in the best interests of shareholders of and contract owners whose contract values are determined by investment in shares of the Acquired Fund, and that the interests of existing shareholders and contract owners will not be diluted as a result of the Reorganization.

In determining whether to approve the Reorganization and recommend its approval to shareholders of the Acquired Fund, the Board inquired into a number of matters and considered, with respect to the Reorganization, the following factors, among others: (1) the compatibility of the investment objectives, policies and risks of the Acquired and Acquiring Funds; (2) the comparative historical performance of the Acquired and Acquiring Funds; (3) any advantages to shareholders of the Acquired Fund of investing in a larger post-Reorganization asset pool having the potential for greater diversification; (4) the prospects for growth, and for achieving economies of scale, of the combined Acquired and Acquiring Funds; (5) the expense ratios and available information regarding the fees and expenses of the Acquired and Acquiring Funds; (6) the investment experience, expertise and financial resources of, and the nature and quality of the services provided by the Advisor and the subadvisor of the Acquiring Fund; (7) the terms and conditions of the Reorganization and whether the Reorganization would result in dilution of shareholder or contract owner interests; (8) any direct and indirect costs to be incurred by the Acquired Funds as a result of the Reorganization; (9) any direct or indirect benefits to the Advisor or its affiliates to be realized as a result of the Reorganization; (10) the tax consequences of the Reorganization on variable contract owners; and (11) possible alternatives to the Reorganization, including liquidation of the Acquired Fund.

In addition to the factors set forth above, the Board also took into account the specific factors listed below with respect to the Acquired and Acquiring Funds in connection with its decision to recommend approval of the Reorganization on behalf of the Acquired Fund. With respect to performance information, the Board reviewed information as of September 30, 2025. With respect to the operating expenses, the Board reviewed information for the 12-month period ended June 30, 2025.

**<u>Proposal – American International Trust (Acquired Fund) into Disciplined Value International Trust (Acquiring Fund)</u>**

First, a combined fund offers economies of scale that may lead to lower per-share fund expenses in the future. Each Fund incurs costs for legal, accounting, transfer agency services, insurance, and custodial and administrative services, directly or in the Acquired Fund's case, indirectly. Many of these resources and costs are duplicative.

------

##### [**Table of Contents**](#toc)
Second, the Reorganization would permit the Acquired Fund's shareholders and contract owners to pursue a similar investment objective in a potentially larger fund with similar principal investment strategies. The greater asset size of the combined fund may allow the Acquiring Fund, relative to the Acquired Fund, to reduce per-share expenses by spreading fixed costs over a larger asset base.

*Third*, on a *pro forma* basis, the net operating expense ratios of each class of shares of the Acquiring Fund to be received in the Reorganization are estimated to be lower than the current expense ratios for the corresponding class of shares of the Acquired Fund to be exchanged both before and after expense waivers.

*Fourth*, the Acquiring Fund has outperformed the Acquired Fund for the year to date, 1-year, 5-year and 10-year periods although it is understood that no assurances may be given that the combined Fund will achieve any particular level of performance after the Reorganization. Further, the Acquiring Fund will be the accounting survivor of the Reorganization. As such, the Acquiring Fund will continue to have the same performance history following the Reorganization as it had prior to the Reorganization.

*Fifth*, the Acquiring Fund Advisor will continue to provide the same advisory services to the combined fund as it did to the Acquiring Fund. Boston Partners is currently the subadvisor to the Acquiring Fund and is proposed to continue to serve as the subadvisor to the Acquiring Fund, following the Reorganization. Boston Partners is expected to continue to provide investment advisory services and personnel to the combined fund of at least the same quality as the services the Master Fund Advisor currently provides to the Master Fund of the Acquired Fund. The Acquiring Fund's portfolio management team consists of: Christopher Hart, CFA, Joshua Jones, CFA and Soyoun Song. The portfolio management team of the combined fund will be the same as the current portfolio management team of the Acquiring Fund.

*Sixth,* assuming certain conditions are satisfied, the Reorganization will not be a taxable event for contract owners whose contract values are determined by investment in shares of one of the funds.

The Board, including the Independent Trustees, also approved the Reorganization on behalf of the Acquiring Fund.

**Description of the Securities to Be Issued** 

JHVIT has an unlimited number of authorized shares of beneficial interest. These authorized shares may be divided into series and classes thereof. The Declaration of Trust authorizes the Board, without shareholder approval, to issue shares in different series, to create new series, to name the rights and preferences of the shareholders of each of the series, to approve mergers of series (to the extent consistent with applicable laws and regulations) and to designate a class of shares of a series as a separate series.

The Acquired and Acquiring Funds are separate series of JHVIT. The shares of JHVIT may be issued in four classes: Series I, Series II, Series III and Series NAV shares. Not all JHVIT funds have established or are currently authorized to offer all classes of shares, and additional classes may be offered in the future. Currently, the Acquired Fund has Series I, Series II, and Series III shares issued and outstanding and the Acquiring Fund has Series I, Series II, and Series NAV shares issued and outstanding.

The Acquiring Fund will issue Series I, Series II, and Series NAV shares in connection with the Reorganization. Each such share, when sold in the manner contemplated by the registration statement, will be legally issued. Series I, Series II, and Series NAV shares may not be converted into shares of any other class.

Series I, Series II, Series III, and Series NAV shares of the Funds, as applicable, are the same except for differences in class expenses, including different Rule 12b-1 fees for Series I, Series II, and Series III and, as described below, voting rights.

JHVIT has adopted a Distribution Plan under Rule 12b-1 under the 1940 Act for Series I, Series II, and Series III shares of each fund, as applicable. Series NAV shares are not subject to Rule 12b-1 fees. Series I and Series II shares of Disciplined Value International Trust are subject to Rule 12b-1 fees amounting to 0.05% and 0.25%, respectively, in each case as a percentage of the average daily net assets of the particular class. Series I, Series II, and Series III shares of American International Trust are subject to Rule 12b-1 fees amounting to 0.60%, 0.75%, and 0.25%, respectively, in each case as a percentage of the average daily net assets of the particular class.

------

##### [**Table of Contents**](#toc)
**Other Matters Regarding Certain Contract Holders** 

John Hancock USA and John Hancock NY have reported to JHVIT that in connection with the Reorganization of American International Trust into Disciplined Value International Trust, in order to conform with the product features of certain variable life insurance and variable annuity contracts, the insurer will, in the case of Series I shares and Series II shares issued by Disciplined Value International Trust in the Reorganization that are attributable to these particular contracts, replace such Series I shares and Series II shares with a number of Series NAV and Series I shares, respectively, having an aggregate value equal to the replaced Series I shares and Series II shares. This replacement is expected to occur because of certain product features associated with these particular contracts that contemplate investment in Series NAV and Series I shares of certain funds where available, and not Series I shares and Series II shares.

These replacements will not occur for other John Hancock USA and John Hancock NY variable life insurance and variable annuity contracts that invest in the same series of shares of these funds because the product features of those contracts contemplate investment in Series I shares and Series II shares of JHVIT. These replacements will not result in any additional cost for the owners of the affected variable life insurance and variable annuity contracts or for the Acquiring Fund and, as a result of each replacement, affected contract holders will have contract values invested in a class with lower expenses than would have been the case otherwise.

**Federal Income Tax Consequences** 

As a condition to the consummation of the Reorganization, JHVIT will have received one or more opinions of K&L Gates LLP, dated on or before the Effective Time of the Reorganization, addressed to and in form and substance satisfactory to JHVIT that, assuming the variable contracts and the insurance companies issuing them are properly structured under the insurance company provisions of the Internal Revenue Code of 1986, as amended (the "Code"), the Reorganization will not be a taxable event for contract owners whose contract values are determined by investment in shares of the Acquired Fund. For purposes of rendering its opinion, K&L Gates LLP may rely exclusively and without independent verification, as to factual matters, on the statements made in the Plan, this Proxy Statement/Prospectus and related SAI, and on such other written representations as will have been verified as of the Effective Time of the Reorganization.

None of JHVIT, the Acquired Fund, or the Acquiring Fund has sought a tax ruling from the Internal Revenue Service (the "IRS"), but each is acting in reliance upon the opinions of counsel discussed in the previous paragraph. The opinions are not binding on the IRS and do not preclude the IRS from adopting a contrary position. Contract owners should consult their own tax advisors concerning the potential tax consequences, including state and local income taxes.

**CAPITALIZATION** 

The following table shows as of June 30, 2025, with respect to the Proposal: (1) the capitalization of the Acquired Fund; (2) the capitalization of the Acquiring Fund; and (3) the *pro forma* combined capitalization of the Acquiring Fund, showing the effect of the Reorganization. The information in Item 3 of the table shows pro rata capitalization information as if the Reorganization had occurred as of that date, adjusted to reflect the expenses of the Reorganization. The table does not show the actual numbers of shares of the Acquiring Fund to be issued in connection with the Reorganization, which will depend upon the net asset value and number of shares outstanding of the Acquired and Acquiring Fund at the time of the Reorganization.

------

##### [**Table of Contents**](#toc)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  **Capitalization Table** |  |  |  |  |
| **Funds** |  | Net Assets ($) | Net Asset Value<br>Per Share ($) | Shares<br>Outstanding |
|  (**1) American International Trust**<br> (Acquired Fund) | - Series I<sup>1</sup> | $138773114 | $16.51 | 8403131 |
|  (**1) American International Trust**<br> (Acquired Fund) | - Series II<sup>1</sup> | $204453768 | $16.50 | 12393013 |
|  (**1) American International Trust**<br> (Acquired Fund) | - Series III<sup>1</sup> | $26614321 | $16.46 | 1617037 |
|  (**1) American International Trust**<br> (Acquired Fund) |  |  |  |  |
|  | **Total** | $369841203 |  | 22413181 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduction in net assets and decrease in net asset values per share to reflect the estimated expenses of the Reorganization, and decreases in outstanding shares relative to net asset value upon the Reorganization in the Acquired Fund. | - Series I | $(68526) | $0.00 | (498563) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduction in net assets and decrease in net asset values per share to reflect the estimated expenses of the Reorganization, and decreases in outstanding shares relative to net asset value upon the Reorganization in the Acquired Fund. | - Series II | $(100958) | $(0.01) | (823696) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduction in net assets and decrease in net asset values per share to reflect the estimated expenses of the Reorganization, and decreases in outstanding shares relative to net asset value upon the Reorganization in the Acquired Fund. | - Series III | $(13142) | $(0.01) | (99571) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduction in net assets and decrease in net asset values per share to reflect the estimated expenses of the Reorganization, and decreases in outstanding shares relative to net asset value upon the Reorganization in the Acquired Fund. |  |  |  |  |
|  | **Total** | $(182626) |  | (1421830) |
| **(2) Disciplined Value International Trust** <br>(Acquiring Fund) | - Series I | $81418267 | $17.70 | 4599089 |
| **(2) Disciplined Value International Trust** <br>(Acquiring Fund) | - Series II | $47199645 | $17.66 | 2672788 |
| **(2) Disciplined Value International Trust** <br>(Acquiring Fund) | - Series NAV | $173853479 | $17.53 | 9917389 |
| **(2) Disciplined Value International Trust** <br>(Acquiring Fund) |  |  |  |  |
|  | **Total** | $302471391 |  | 17189266 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduction in net assets and no changes in net asset values per share to reflect the estimated expenses of the Reorganization, and increase in outstanding shares relative to net asset value upon the Reorganization in the Acquiring Fund. | - Series I | $(4346) | $0.00 | 1775509 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduction in net assets and no changes in net asset values per share to reflect the estimated expenses of the Reorganization, and increase in outstanding shares relative to net asset value upon the Reorganization in the Acquiring Fund. | - Series II | $(2520) | $0.00 | 10602729 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduction in net assets and no changes in net asset values per share to reflect the estimated expenses of the Reorganization, and increase in outstanding shares relative to net asset value upon the Reorganization in the Acquiring Fund. | - Series NAV | $(9281) | $0.00 | 8613113 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduction in net assets and no changes in net asset values per share to reflect the estimated expenses of the Reorganization, and increase in outstanding shares relative to net asset value upon the Reorganization in the Acquiring Fund. |  |  |  |  |
|  | **Total** | $(16147) |  | 20991351 |
| **(3) Disciplined Value International Trust** | - Series I | $112840421 | $17.70 | 6374598 |
| **(3) Disciplined Value International Trust** | - Series II | $234441328 | $17.66 | 13275517 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Acquiring Fund) (*Pro forma* assuming combination of (1) and (2)) | - Series NAV | $324832072 | $17.53 | 18530502 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Acquiring Fund) (*Pro forma* assuming combination of (1) and (2)) |  |  |  |  |
|  | **Total** | $672113821 |  | 38180617 |

---

------

##### [**Table of Contents**](#toc)
1. Note that approximately 10% of JHVIT American International Trust Series I net assets will transfer to JHVIT
Disciplined Value International Trust Series I and approximately 90% of JHVIT American International Trust Series I net assets will transfer to JHVIT Disciplined Value International Trust Series NAV. Approximately 92% of JHVIT American International
Trust Series II will transfer to JHVIT Disciplined Value International Trust Series II and approximately 8% of JHVIT American International Trust Series II net assets will transfer to JHVIT Disciplined Value International Trust Series I. JHVIT
American International Trust Series III will transfer 100% of net assets to JHVIT Disciplined Value International Series NAV.

---

| | | |
|:---|:---|:---|
| **Acquired Class** | **Acquiring Class** | **Asset<br>Allocation%** |
|  JHVIT American International Trust Series I | JHVIT Disciplined Value International Series I | 10% |
|  JHVIT American International Trust Series I | JHVIT Disciplined Value International Series NAV | 90% |
|  JHVIT American International Trust Series II | JHVIT Disciplined Value International Series I | 8% |
|  JHVIT American International Trust Series II | JHVIT Disciplined Value International Series II | 92% |
|  JHVIT American International Trust Series III | JHVIT Disciplined Value International Series NAV | 100% |

---

------

##### [**Table of Contents**](#toc)
**ADDITIONAL INFORMATION ABOUT THE FUNDS** 

The following table shows where in each Fund's prospectus you can find additional information about the Fund. The headings are the same in each Fund's prospectus.

---

| | |
|:---|:---|
| Type of Information | Headings in the Prospectus |
| Investment objective and policies | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Fund Summary: Investment Objective; Principal Investment Strategies; Principal Risks<br>• Principal Risks of Investing<br>|
| Portfolio management | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Fund Summary: Portfolio Management<br>• Management: Subadvisors and Portfolio Managers<br>|
| Expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Fund Summary: Fees and Expenses<br>• Management: Additional information about fund expenses<br>|
| Purchase of shares, Redemptions or sale of shares | &nbsp;&nbsp;&nbsp;&nbsp; • General Information: Purchase and redemption of shares<br>|
| Dividends, distributions, and taxes | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Additional Information about the Funds: Taxes<br>• General Information: Dividends<br>|

---

------

##### [**Table of Contents**](#toc)
**ADDITIONAL INFORMATION ABOUT THE FUNDS** 

**SHAREHOLDERS AND VOTING INFORMATION** 

**Shareholders of JHVIT** 

JHVIT does not sell its shares directly to the public but generally only to insurance companies and their separate accounts as the underlying investment media for variable contracts issued by such companies, certain entities affiliated with the insurance companies and those funds of JHVIT that operate as funds of funds and invest in other JHVIT funds (the "Funds of Funds"). Only shares of a particular fund are entitled to vote on matters that affect only the interests of that fund.

As of the Record Date, shares of JHVIT were legally owned by John Hancock USA and John Hancock NY (collectively, the "Insurance Companies") and the Funds of Funds.

The Insurance Companies hold shares principally in their separate accounts. They may also hold shares directly. An Insurance Company may legally own in the aggregate more than 25% of the shares of a fund. For purposes of the 1940 Act, any person who owns "beneficially" more than 25% of the outstanding shares of a fund is presumed to "control" the fund. Shares are generally deemed to be beneficially owned by a person who has the power to vote or dispose of the shares. An Insurance Company has no power to exercise any discretion in voting or disposing of any of the shares that it legally owns, except that it may have the power to dispose of shares that it holds directly. Consequently, an Insurance Company would be presumed to control a fund only if it holds directly for its own account, and has the power to dispose of, more than 25% of the shares of the fund.

The Funds of Funds may invest in Series NAV shares of the Acquiring Fund (the "Underlying Fund"). The Funds of Funds, individually or collectively, may hold more than 25% of the shares of an Underlying Fund. As currently operated, the Funds of Funds have no power to exercise any discretion in voting these shares, and the power to dispose of the shares resides not with the Funds of Funds or with JHVIT but rather with the subadvisor(s) to each Fund of Funds as a result of its subadvisory arrangements. Under these circumstances, JHVIT does not view a Fund of Funds as being the beneficial owner of shares of Underlying Funds for purposes of the 1940 Act presumption of control. See "Solicitation of Proxies and Voting Instructions" below.

John Hancock USA is a stock life insurance company existing under the laws of Michigan and having its principal address at 200 Bloor Street East, Toronto, Ontario, Canada M4W 1E5. John Hancock NY is a stock life insurance company organized under the laws of New York and having its principal address at 100 Summit Lake Drive, Second Floor, Valhalla, New York 10595. Each Insurance Company is a wholly-owned subsidiary of The Manufacturers Life Insurance Company ("Manulife"), a Canadian stock life insurance company. The ultimate parent entity of the John Hancock Insurance Companies is MFC, the holding company of Manulife and its subsidiaries, collectively known as "Manulife Financial." The principal offices of MFC are located at 200 Bloor Street East, Toronto, Ontario, Canada M4W 1E5.

The number of votes eligible to be cast at the Meeting or outstanding with respect to each fund, the percentage ownership of the outstanding shares of each fund by each of the Insurance Companies and by the Funds of Funds, and other share ownership information, as of the Record Date, are set forth below under "Outstanding Shares and Share Ownership."

**Voting Procedures** 

Proxies from shareholders may be revoked at any time prior to the voting of the shares represented thereby by: (i) mailing written instructions addressed to the Secretary of JHVIT at 200 Berkeley Street, Boston, Massachusetts 02116; (ii) signing and returning a new proxy, in each case if received by JHVIT by the close of business on **April 6, 2026;** or (iii) attending the Meeting and voting shares. All valid proxies will be voted in accordance with specifications thereon, or in the absence of specifications, for approval of all applicable Proposals. Instructions from contract owners may be revoked by: (i) mailing written instructions addressed to the Secretary of JHVIT at 200 Berkeley Street, Boston, Massachusetts 02116; or (ii) signing and returning a new voting instructions form, in each case if received by JHVIT by the close of business on **April 6, 2026**.

------

##### [**Table of Contents**](#toc)
*Quorum; Definition of a Majority of Outstanding Voting Securities*. Shareholders of record at the close of business on the Record Date will be entitled to vote at the Meeting or any adjournment of the Meeting. The holders of 30% of the outstanding shares of JHVIT (or of a fund or class of shares of a fund, as applicable) at the close of business on that date present in person or by proxy will constitute a quorum for the Meeting. A Majority of the Outstanding Voting Securities (defined below) of JHVIT (or of a fund or class of shares of a fund, as applicable) is required to approve a proposal. As used in this Proxy Statement/Prospectus, the vote of a "Majority of the Outstanding Voting Securities" means the affirmative vote of the lesser of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) 67% or more of the voting securities of a fund present at the Meeting, if the holders of more than 50% of the outstanding voting securities of the fund are present in person or by proxy; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) more than 50% of the outstanding voting securities of the fund.

Shareholders are entitled to one vote for each Series I, Series II, and Series NAV share held and fractional votes for fractional shares held. No shares have cumulative voting rights.

In the event the necessary quorum to transact business or the vote required to approve a proposal is not obtained at the Meeting, the persons named as proxies may propose one or more adjournments of the Meeting with respect to one or more proposals in accordance with applicable law to permit further solicitation of proxies. Any adjournment of the Meeting generally will require the affirmative vote of the holders of a majority of JHVIT's shares cast at the Meeting, and any adjournment with respect to a proposal will require the affirmative vote of the holders of a majority of the shares entitled to vote on the proposal cast at the Meeting. The persons named as proxies will vote for or against any adjournment in their discretion. Because shares for which voting instructions are not timely received will nevertheless be voted in proportion to votes each of John Hancock USA and John Hancock NY receives, all shares will be voted at the meeting and thus the presence of a quorum is assured.

*Abstentions*. Abstentions are counted as shares eligible to vote at the Meeting in determining whether a quorum is present, but do not count as votes cast with respect to a proposal. Under the 1940 Act, the affirmative vote necessary to approve a matter under consideration may be determined with reference to a percentage of votes present at the Meeting, which would have the effect of treating abstentions as if they were votes against a proposal.

*Cost of Preparation and Distribution of Proxy Materials*. The projected expenses of the Reorganization are $198,773, of which $182,626 will be borne by the Acquired Fund (amounting to four basis points and less than $0.01 per share) and $16,147 will be borne by the Acquiring Fund (amounting to less than one basis point and less than $0.01 per share). In addition to the solicitation of proxies by the use of the mails, proxies may be solicited by officers and employees of JHVIT, the Advisor or its agents or affiliates, personally or by telephone. Brokerage houses, banks and other fiduciaries may be requested to forward soliciting materials to their principals and to obtain authorization for the execution of proxies.

*Fund Voting*. Shares of the Acquired Fund will vote in the aggregate, and not by class of shares, with respect to each proposal.

If the required shareholder approval is not obtained, the Acquired Fund will continue to operate indefinitely as a separate series of the Trust, or until the Board takes other action with respect to the Acquired Fund.

**Solicitation of Proxies and Voting Instructions** 

JHVIT is soliciting proxies from the shareholders of the Acquired Fund, including the Insurance Companies, which have the right to vote upon matters that may be voted upon at a special shareholders' meeting. The Insurance Companies will furnish this Proxy Statement/Prospectus to the owners of variable contracts participating in their separate accounts that are registered with the SEC under the 1940 Act ("Registered Accounts") and that hold shares of the Acquired Fund to be voted at the Meeting and will solicit voting instructions from those contract owners.

------

##### [**Table of Contents**](#toc)
Each Insurance Company will vote shares of the Acquired Fund held in its Registered Accounts: (i) for which timely voting instructions are received from contract owners, in accordance with such instructions; and (ii) for which no voting instructions are timely received, in the same proportion as the instructions received from contract owners participating in all its Registered Accounts. The Insurance Companies will vote all other shares of the Acquired Funds held by them in the same proportion as the voting instructions timely received by all the Insurance Companies from contract owners participating in all their Registered Accounts. The effect of proportional voting as described above is that a small number of contract owners can determine the outcome of the voting.

**OUTSTANDING SHARES AND SHARE OWNERSHIP** 

**Principal Holders**. The following sets forth the principal holders of the shares of each fund. Principal holders are those who own of record or are known by JHVIT to own beneficially 5% or more of a series of a fund's outstanding shares.

As of the Record Date, the number of votes eligible to be cast at the Meeting with respect to each class of shares of the Acquired Fund, and the percentage ownership thereof by John Hancock USA, John Hancock NY and collectively by the Funds of Funds are set forth below:

**Acquired Fund** 

As of the Record Date, the number of votes eligible to be cast at the Meeting with respect to Series I, Series II, and Series III shares of the Acquired Fund, and the percentage ownership thereof by John Hancock USA and John Hancock NY, and collectively by the Funds of Funds are set forth below:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | | | | **Percentage of Shares Held by** | **Percentage of Shares Held by** | **Percentage of Shares Held by** |
| **Acquired Fund** | <br>**Share Class** | <br>**Number of**<br> **Outstanding**<br> **Shares** |<br>**Number of<br>Eligible Votes** | **JH USA** | **JH NY** | **Funds of<br>Funds\*** |
|  American International Trust | Series I |  |  |  |  |  |
|  | Series II |  |  |  |  |  |
|  | Series III |  |  |  |  |  |

---

\* Represents the aggregate percentage ownership of the Funds of Funds. 

As of the Record Date, Trustees and officers of JHVIT, in the aggregate, beneficially owned less than 1% of the outstanding shares of any class of the Acquired Fund.

**Acquiring Fund** 

As of the Record Date, the share of each class of the Acquiring Fund, and the percentage ownership thereof by John Hancock USA, John Hancock NY, and collectively by the Funds of Funds are set forth below:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | | | **Percentage of Shares Held by** | **Percentage of Shares Held by** | **Percentage of Shares Held by** |
| **Acquiring Fund** | <br>**Share Class** | <br>**Number of**<br> **Outstanding**<br> **Shares** | **JH USA** | **JH NY** | **Funds of<br>Funds\*** |
|  Disciplined Value International Trust | Series I |  |  |  |  |
|  | Series II |  |  |  |  |
|  | Series NAV |  |  |  |  |

---

\* Represents the aggregate percentage ownership of the Funds of Funds. 

As of the Record Date, Trustees and officers of JHVIT, in the aggregate, beneficially owned less than 1% of the outstanding shares of any class of the Acquiring Fund.

**FINANCIAL STATEMENTS; EXPERTS** 

The financial statements of JHVIT included in its Annual Report to Shareholders for the fiscal year ended December 31, 2024 (File Nos. 2-94157; 811-04146) have been audited by PricewaterhouseCoopers LLP ("PwC"). These financial statements have been incorporated by reference into the SAI insofar as they relate to the Acquired and Acquiring Funds. The audited financial highlights of the Acquired and Acquiring Funds for the five years ended December 31, 2024 are included in Appendix B to this Proxy Statement/Prospectus.

------

##### [**Table of Contents**](#toc)
The audited annual financial statements and financial highlights have been included in reliance on the reports of PwC, given on its authority as an expert in accounting and auditing.

JHVIT will furnish, without charge, copies of its Annual Report for the fiscal year ended December 31, 2024 to any shareholder or contract owner upon request. To obtain a report, please contact JHVIT by calling 1-800-344-1029 or by writing to JHVIT at 200 Berkeley Street, Boston, Massachusetts 02116, Attn.: Treasurer. JHVIT's Annual Report for the fiscal year ended December 31, 2024 was filed with the SEC on March 6, 2025.

**LEGAL MATTERS** 

Certain matters concerning the issuance of shares of the Acquiring Fund will be passed upon by Harsha Pulluru, Esq., Counsel, U.S. Operations Law Department, John Hancock. Certain tax consequences of the Reorganization will be passed upon by K&L Gates LLP, One Congress Street, Boston, Massachusetts 02111.

**OTHER MATTERS** 

The Board does not know of any matters to be presented at the Meeting other than those mentioned in this Proxy Statement/Prospectus. If any other matters properly come before the Meeting, the shares represented by proxies will be voted in accordance with the best judgment of the person or persons voting the proxies.

JHVIT is not required to hold annual meetings of shareholders and, therefore, it cannot be determined when the next meeting of shareholders will be held. Shareholder proposals to be presented at any future meeting of shareholders of JHVIT must be received by JHVIT a reasonable time before JHVIT's solicitation of proxies for that meeting in order for such proposals to be considered for inclusion in the proxy materials related to that meeting.

**BY ORDER OF THE BOARD OF TRUSTEES** 

[February ], 2026

Boston, Massachusetts

**It is important that voting instructions be returned promptly. Therefore, shareholders who do not expect to attend the Meeting in person are urged to complete, sign and date the Voting Instructions Form and return it in the enclosed envelope.** 

------

##### [**Table of Contents**](#toc)
**Appendix A** 

**FORM OF AGREEMENT AND PLAN OF REORGANIZATION** 

**THIS AGREEMENT AND PLAN OF REORGANIZATION** (the "Plan") is made this [ ] day of April 2026, among John Hancock Variable Insurance Trust ("JHVIT"), a Massachusetts business trust, on behalf of American International Trust (the "Fund" or "Acquired Fund") and Disciplined Value International Trust (the "Acquiring Fund"), each of which is a separate series or fund of JHVIT, and, solely with respect to Section 9, John Hancock Variable Trust Advisers LLC ("JHVTA").

This Plan shall be deemed to be a separate agreement by JHVIT on behalf of the Acquired Fund and the Acquiring Fund.

**WHEREAS**, JHVIT intends to provide for the reorganization (the "Reorganization") of the Acquired Fund through the acquisition by the Acquiring Fund of all assets, known or unknown, fixed or contingent, subject to all of the liabilities, known or unknown, fixed or contingent, of the Acquired Fund in exchange for Series I, Series II, and Series NAV voting shares of beneficial interest, par value $.01 per share, of the Acquiring Fund (the "Acquiring Fund Shares"), the liquidation of the Acquired Fund and the distribution to Acquired Fund shareholders of the Acquiring Fund Shares; and

**WHEREAS**, the Board of Trustees of JHVIT (the "Board") has determined that the transfer of all or substantially all of the assets and all of the liabilities of the Acquired Fund to the Acquiring Fund is in the best interests of each such series, as well as the best interests of shareholders and owners of variable life and annuity contracts funded by shares of such series ("contract owners"), and that the interests of existing shareholders and contract owners will not be diluted as a result of the Reorganization;

**NOW, THEREFORE**, in consideration of the mutual promises herein contained, JHVIT on behalf of, respectively, the Acquired Fund and the Acquiring Fund, and JHVTA with respect to Section 9 of the Plan only, hereto agree as follows:

**1. Transfer of Assets of the Acquired Fund in Exchange for Acquiring Fund Shares and Liquidation of the Acquired Fund** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) *Plan of Reorganization*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) JHVIT on behalf of the Acquired Fund, will convey, transfer and deliver to the Acquiring Fund all known or unknown, fixed or contingent assets of the Acquired Fund (consisting, without limitation, of portfolio securities and instruments, dividend and interest receivables, cash, claims (whether absolute or contingent, known or unknown, accrued or unaccrued) and other assets). In consideration thereof, JHVIT on behalf of the Acquiring Fund will (A) assume and pay, all of the known or unknown, fixed or contingent obligations and liabilities of the Acquired Fund and (B) issue and deliver to the Acquired Fund that number of full and fractional Series I, Series II, and Series NAV shares of beneficial interest of the Acquiring Fund as determined in Section 1(c) hereof. Any Series I, Series II, and Series NAV shares of beneficial interest, par value $.01 per share, of the Acquired Fund ("Acquired Fund Shares") held in the treasury of JHVIT at the Effective Time of the Reorganization (as defined in Section 1(b)(i) hereof) shall thereupon be retired. Such transactions shall take place on the date provided for in Section 1(b)(i) hereof (the "Exchange Date"). All computations for the Acquired Fund and the Acquiring Fund shall be performed by each Fund's respective custodian (the "Acquired Fund Custodian" and the Acquiring Fund Custodian," respectively). State Street Bank and Trust Company serves as custodian and pricing agent for the Acquired Fund. Citibank, NA serves as custodian and pricing agent for the Acquiring Fund. The determination of the Acquired Fund Custodian and the Acquiring Fund Custodian shall be conclusive and binding on all parties in interest. For purposes of this Plan and this Section 1(a)(i) in particular, Series III shares of American International Trust shall be deemed to correspond to Series NAV shares of Disciplined Value International Trust.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) As of the Effective Time of the Reorganization, the Acquired Fund will liquidate and distribute pro rata to its shareholders of record ("Acquired Fund shareholders") as of the Effective Time of the Reorganization the Acquiring Fund Shares received by the Acquired Fund pursuant to Section 1(a)(i) in actual or constructive exchange for the shares of the Acquired Fund held by the Acquired Fund shareholders. The holders of

------

##### [**Table of Contents**](#toc)
Series I, Series II, and Series III shares of American International Trust will receive Series I, Series II, and Series NAV shares of Disciplined Value International Trust, respectively. Such liquidation and distribution will be accomplished by the transfer of the Acquiring Fund Shares then credited to the account of the Acquired Fund on the books of the Acquiring Fund to open accounts on the share records of the Acquiring Fund in the names of the Acquired Fund shareholders and representing the respective pro-rata number of the Acquiring Fund Shares due such shareholders. The Acquiring Fund will not issue certificates representing the Acquiring Fund Shares in connection with such exchange. The exchange of the Acquired Fund's shares for the Acquiring Fund's shares shall constitute a full cancellation of those shares and shall terminate any continuing rights of the holders of such Acquired Fund shares as such.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) With respect to the Reorganization, as soon as practicable after the Effective Time of the Reorganization, JHVIT shall take all the necessary steps under Massachusetts law, JHVIT's Agreement and Declaration of Trust (the "Declaration of Trust") and any other applicable law to effect a complete dissolution of the Acquired Fund.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) *Exchange Date and Effective Time of the Reorganization*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Subject to the satisfaction of the conditions to the Reorganization specified in this Plan, the Reorganization shall occur as of the close of regularly scheduled trading on the New York Stock Exchange (the "NYSE") (the "Effective Time of the Reorganization") on the day (the "Exchange Date") which is the later of: (A) the final adjournment of the meeting of the holders of Acquired Fund shares at which this Plan will be considered; (B) April 24, 2026; or (C) such later day as any one or more of the officers of JHVIT may determine.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) All acts taking place on the Exchange Date shall be deemed to take place simultaneously as of the Effective Time of the Reorganization, unless otherwise provided.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) In the event that on the proposed Exchange Date: (A) the NYSE shall be closed to trading or trading thereon shall be restricted; or (B) trading or the reporting of trading on said Exchange or elsewhere shall be disrupted so that accurate valuation of the net assets of the Acquiring Fund or the Acquired Fund is impracticable, the Exchange Date shall be postponed until the first business day after the day when trading shall have been fully resumed and reporting shall have been restored.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) On the Exchange Date, portfolio securities of the Acquired Fund shall be transferred by the Acquired Fund Custodian to the Acquiring Fund Custodian for the account of the Acquiring Fund duly endorsed in proper form for transfer, in such condition as to constitute good delivery thereof in accordance with the custom of brokers, and shall be accompanied by all necessary federal and state stock transfer stamps or a check for the appropriate purchase price thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) *Valuation*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) The net asset value per share of Series I, Series II, and Series NAV shares of the Acquiring Fund and the net value of the assets of the Acquired Fund to be transferred in exchange for such Series I, Series II, and Series NAV shares shall be determined as of the Effective Time of the Reorganization. The net asset value per share of Series I, Series II, and Series NAV shares of the Acquiring Fund shall be computed by the Acquiring Fund Custodian in the manner set forth in the Declaration of Trust or JHVIT's By-laws (the "By-laws") and then-current prospectus and statement of additional information and shall be computed to not less than two decimal places. The net value of the assets of the Acquired Fund to be transferred shall be computed by the Acquired Fund Custodian by calculating the value of the assets of the Acquired Fund and by subtracting therefrom the amount of the liabilities assigned and transferred to the Acquiring Fund, said assets and liabilities to be valued in the manner set forth in the Declaration of Trust or By-laws and then-current prospectus and statement of additional information.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) The number of Series I, Series II, and Series NAV shares of the Acquiring Fund to be issued (including fractional shares, if any) by the Acquiring Fund in exchange for the Acquired Fund's assets shall be determined by dividing the net value of the assets of the Acquired Fund attributable to shares of each class to be transferred by the net asset value per share of the shares of the Acquiring Fund to be exchanged for each such class of shares of the Acquired Fund, in each case as determined in accordance with Section 1(c)(i).

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) All computations of value shall be made by the Acquiring Fund Custodian and the Acquired Fund Custodian in accordance with their regular practice as pricing agents for the Acquiring Fund and the Acquired Fund, respectively.

**2. Representations and Warranties of JHVIT on Behalf of the Acquiring Fund** 

JHVIT on behalf of the Acquiring Fund represents and warrants as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) *Organization, Existence, etc*. JHVIT is a business trust that is duly organized, validly existing under the laws of the Commonwealth of Massachusetts and has the power to carry on its business as it is now being conducted. The Acquiring Fund is a validly existing series of shares of such business trust representing interests in a separate portfolio thereof under the laws of Massachusetts. Each of the Acquiring Fund and JHVIT has all necessary federal, state and local authorization to own all of its properties and assets and to carry on its business as now being conducted.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) *Registration as Investment Company*. JHVIT is registered under the Investment Company Act of 1940, as amended (the "1940 Act"), as an open-end management investment company; such registration has not been revoked or rescinded and is in full force and effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) *Current Offering Documents*. The current prospectus of JHVIT dated April 28, 2025, as supplemented, and the current statement of additional information of JHVIT dated April 28, 2025, as it relates to the Acquiring Fund, as supplemented, and as it may be further supplemented or amended, included in JHVIT's registration statement on Form N-1A filed with the Securities and Exchange Commission (the "Commission"), comply in all material respects with the requirements of the Securities Act of 1933, as amended (the "Securities Act"), and the 1940 Act and do not contain an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) *Capitalization*. JHVIT has an unlimited number of authorized shares of beneficial interest, par value $.01 per share. All of the outstanding shares of JHVIT have been duly authorized and are validly issued, fully paid and non-assessable (except as disclosed in JHVIT's prospectus and recognizing that under Massachusetts law, shareholders of a series of JHVIT could, under certain circumstances, be held personally liable for the obligations of such series). All of the issued and outstanding shares of the Acquiring Fund have been offered and sold in compliance in all material respects with applicable registration requirements of the Securities Act and applicable state securities laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) *Financial Statements*. The financial statements of the Acquiring Fund for the fiscal year ended December 31, 2024, which have been audited by the independent registered public accounting firm retained by JHVIT fairly present the financial position of the Acquiring Fund as of the date thereof and its results of operations and changes in net assets for the period indicated in accordance with generally accepted accounting principles ("GAAP").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) *Shares to be Issued Upon Reorganization*. The Acquiring Fund Shares to be issued in connection with the Reorganization will be duly authorized and upon consummation of the Reorganization will be validly issued, fully paid and non-assessable (except as disclosed in the Acquiring Fund's prospectus and recognizing that under Massachusetts law, shareholders of a series of JHVIT could, under certain circumstances, be held personally liable for the obligations of such series).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) *Authority Relative to this Plan*. JHVIT, on behalf of the Acquiring Fund, has the power to enter into this Plan and to carry out its obligations hereunder. The execution and delivery of this Plan and the consummation of the transactions contemplated hereby have been duly authorized by the Board and no other proceedings by JHVIT other than those contemplated under this Plan are necessary to authorize its officers to effectuate this Plan and the transactions contemplated hereby. JHVIT is not a party to or obligated under any provision of its Declaration of Trust or By-laws, or under any indenture or contract provision or any other commitment or obligation, or subject to any order or decree, that would be violated by or that would prevent its execution and performance of this Plan in accordance with its terms.

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) *Liabilities*. There are no known liabilities of the Acquiring Fund, whether actual or contingent and whether or not determined or determinable, other than liabilities disclosed or provided for in the Acquiring Fund's Financial Statements and liabilities incurred in the ordinary course of business subsequent to December 31, 2024 or otherwise previously disclosed to the Acquiring Fund, none of which has been materially adverse to the business, assets or results of operations of the Acquiring Fund.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) *No Material Adverse Change*. Since December 31, 2024, there has been no material adverse change in the financial condition, results of operations, business, properties or assets of the Acquiring Fund, other than those occurring in the ordinary course of business (for these purposes, a decline in net asset value and a decline in net assets due to redemptions do not constitute a material adverse change).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) *Litigation*. There are no claims, actions, suits or proceedings pending or, to the knowledge of JHVIT, threatened that, if adversely determined, would materially and adversely affect the Acquiring Fund's assets or business or that would prevent or hinder consummation of the transactions contemplated hereby, there are no facts that would form the basis for the institution of administrative proceedings against the Acquiring Fund and, to the knowledge of JHVIT, there are no regulatory investigations of the Acquiring Fund, pending or threatened, other than routine inspections and audits.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) *Contracts*. No default exists under any material contract or other commitment on behalf of the Acquiring Fund to which JHVIT is subject.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) *Taxes*. All federal and other income tax returns of the Acquiring Fund required to be filed by JHVIT have been filed for all taxable years to and including December 31, 2023, and all taxes payable pursuant to such returns have been paid. To the knowledge of JHVIT, no such return is under audit and no assessment has been asserted in respect of any such return. All federal and other taxes owed by the Acquiring Fund have been paid so far as due. The Acquiring Fund currently is, at all times since its inception has been, and will continue to be up until and at the Exchange Date, in compliance with Section 817(h)(1) of the Internal Revenue Code of 1986, as amended (the "Code"), and Treas. Reg. Section 1.817-5, as if those provisions applied directly to the Acquiring Fund, relating to the diversification requirements for variable annuity, endowment and life insurance contracts. The Acquiring Fund's shares are (and since its inception have been) held only by (a) insurance company "segregated asset accounts" within the meaning of Treas. Reg. Section 1.817-5(e) and (b) other purchasers of the kind specified in Treas. Reg. Section 1.817-5(f)(3) as from time to time in effect. The Acquiring Fund is, and at all times since its inception has been, qualified as a "regulated investment company" under subchapter M of the Code.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) *No Approvals Required*. Except for the effectiveness of the Registration Statement (as defined in Section 4(a) hereof) and the approval of the Acquired Fund's shareholders (referred to in Section 6(a) hereof), no consents, approvals, authorizations, registrations or exemptions under federal or state laws are necessary for the consummation by the Acquiring Fund of the Reorganization, except such as have been obtained as of the date hereof.

**3. Representations and Warranties of JHVIT on Behalf of the Acquired Fund** 

JHVIT on behalf of the Acquired Fund represents and warrants as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) *Organization, Existence, etc*. JHVIT is a business trust that is duly organized, validly existing under the laws of the Commonwealth of Massachusetts and has the power to carry on its business as it is now being conducted. The Acquired Fund is a validly existing series of shares of such business trust representing interests in a separate portfolio thereof under the laws of Massachusetts. Each of the Acquired Fund and JHVIT has all necessary federal, state and local authorization to own all of its properties and assets and to carry on its business as now being conducted.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) *Registration as Investment Company*. JHVIT is registered under the 1940 Act as an open-end management investment company; such registration has not been revoked or rescinded and is in full force and effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) *Current Offering Documents*. The current prospectus of JHVIT dated April 28, 2025, as supplemented, and the current statement of additional information of JHVIT dated April 28, 2025, as it relates to the Acquired Fund, as supplemented, and as each may be further supplemented or amended, included in JHVIT's registration statement on Form N-1A filed with the Commission, comply in all material respects with the requirements of the Securities Act and the 1940 Act and do not contain an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) *Capitalization*. JHVIT has an unlimited number of authorized shares of beneficial interest, par value $.01 per share. All of the outstanding shares of JHVIT have been duly authorized and are validly issued, fully paid and non-assessable (except as disclosed in JHVIT's prospectus and recognizing that under Massachusetts law, shareholders of a series of JHVIT could, under certain circumstances, be held personally liable for the obligations of such series). All such shares of the Acquired Fund will, at the Effective Time of the Reorganization, be held by the shareholders of record of the Acquired Fund as set forth on the books and records of JHVIT in the amounts set forth therein, and as set forth in any list of shareholders of record provided to the Acquiring Fund for purposes of the Reorganization, and no such shareholders of record will have any preemptive rights to purchase any Acquired Fund shares, and the Acquired Fund does not have outstanding any options, warrants or other rights to subscribe for or purchase any Acquired Fund shares (other than any existing dividend reinvestment plans of the Acquired Fund or as set forth in this Plan), nor are there outstanding any securities convertible by their terms into any shares of the Acquired Fund (except pursuant to any existing exchange privileges described in the current prospectus and statement of additional information of JHVIT). All of the Acquired Fund's issued and outstanding shares have been offered and sold in compliance in all material respects with applicable registration requirements of the Securities Act and applicable state securities laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) *Financial Statements*. The financial statements of the Acquired Fund for the fiscal year ended December 31, 2024, which have been audited by the independent registered public accounting firm retained by JHVIT fairly present the financial position of the Acquired Fund as of the date thereof and its results of operations and changes in net assets for the period indicated in accordance with GAAP.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) *Authority Relative to this Plan*. JHVIT, on behalf of the Acquired Fund, has the power to enter into this Plan and to carry out its obligations hereunder. The execution and delivery of this Plan and the consummation of the transactions contemplated hereby have been duly authorized by the Board and no other proceedings by JHVIT other than those contemplated under this Plan are necessary to authorize its officers to effectuate this Plan and the transactions contemplated hereby. JHVIT is not a party to or obligated under any provision of its Declaration of Trust or By-laws, or under any indenture or contract provision or any other commitment or obligation, or subject to any order or decree, that would be violated by or that would prevent its execution and performance of this Plan in accordance with its terms.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) *Liabilities*. There are no known liabilities of the Acquired Fund, whether actual or contingent and whether or not determined or determinable, other than liabilities disclosed or provided for in the Acquired Fund's financial statements and liabilities incurred in the ordinary course of business subsequent to December 31, 2024 or otherwise previously disclosed to the Acquired Fund, none of which has been materially adverse to the business, assets or results of operations of the Acquired Fund.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) *No Material Adverse Change*. Since December 31, 2024, there has been no material adverse change in the financial condition, results of operations, business, properties or assets of the Acquired Fund, other than those occurring in the ordinary course of business (for these purposes, a decline in net asset value and a decline in net assets due to redemptions do not constitute a material adverse change).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) *Litigation*. There are no claims, actions, suits or proceedings pending or, to the knowledge of JHVIT, threatened that, if adversely determined, would materially and adversely affect the Acquired Fund's assets or business or that would prevent or hinder consummation of the transactions contemplated hereby, there are no facts that would form the basis for the institution of administrative proceedings against the Acquired Fund and, to the knowledge of JHVIT, there are no regulatory investigations of the Acquired Fund, pending or threatened, other than routine inspections and audits.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) *Contracts*. JHVIT is not subject to any contracts or other commitments on behalf of the Acquired Fund (other than this Plan) that will not be terminated with respect to the Acquired Fund without liability to JHVIT or the Acquired Fund as of or prior to the Effective Time of the Reorganization.

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) *Taxes*. All federal and other income tax returns of the Acquired Fund required to be filed by JHVIT with respect to the Acquired Fund have been filed for all taxable years to and including December 31, 2023, and all taxes payable pursuant to such returns have been paid. To the knowledge of JHVIT, no such return is under audit and no assessment has been asserted in respect of any such return. All federal and other taxes owed by the Acquired Fund have been paid so far as due. The Acquired Fund currently is, at all times since its inception has been, and will continue to be up until and at the Exchange Date, in compliance with Section 817(h)(1) of the Code and Treas. Reg. Section 1.817-5, as if those provisions applied directly to the Acquired Fund, relating to the diversification requirements for variable annuity, endowment and life insurance contracts. The Acquired Fund's shares are (and since its inception have been) held only by (a) insurance company "segregated asset accounts" within the meaning of Treas. Reg. Section 1.817-5(e) and (b) other purchasers of the kind specified in Treas. Reg. Section 1.817-5(f)(3) as from time to time in effect. The Acquired Fund is, and at all times since its inception has been, qualified as a "regulated investment company" under subchapter M of the Code.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) *No Approvals Required*. Except for the effectiveness of the Registration Statement (as defined in Section 4(a) hereof) and the approval of the Acquired Fund's shareholders referred to in Section 6(a) hereof, no consents, approvals, authorizations, registrations or exemptions under federal or state laws are necessary for the consummation by the Acquired Fund of the Reorganization, except such as have been obtained as of the date hereof.

**4. Covenants of JHVIT on Behalf of the Acquiring Fund** 

JHVIT on behalf of the Acquiring Fund covenants to the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) *Registration Statement*. On behalf of the Acquiring Fund, JHVIT shall file with the Commission a Registration Statement on Form N-14 (the "Registration Statement") under the Securities Act relating to the Acquiring Fund Shares issuable hereunder and the proxy statement of the Acquired Fund relating to the meeting of the Acquired Fund's shareholders referred to in Section 5(a) herein. At the time the Registration Statement becomes effective, the Registration Statement: (i) will comply in all material respects with the provisions of the Securities Act and the rules and regulations of the Commission thereunder (the "Regulations"); and (ii) will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; and at the time the Registration Statement becomes effective, at the time of the Acquired Fund's shareholders meeting referred to in Section 5(a) hereof, and at the Effective Time of the Reorganization, the proxy statement/prospectus (the "Prospectus") and statement of additional information (the "SAI") included therein, as amended or supplemented by any amendments or supplements filed by JHVIT, will not contain an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) *Cooperation in Effecting Reorganization*. JHVIT on behalf of the Acquiring Fund agrees to use all reasonable efforts to effectuate the Reorganization, to continue in operation thereafter, and to obtain any necessary regulatory approvals for the Reorganization.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) *Operations in the Ordinary Course*. Except as otherwise contemplated by this Plan, and, in particular, any actions necessary as a result of the circumstances identified in Section 1(a)(ii) of this Plan, JHVIT with respect to the Acquiring Fund shall conduct its business in the ordinary course until the consummation of the Reorganization, it being understood that such ordinary course of business will include the declaration and payment of customary dividends and distributions.

**5. Covenants of JHVIT on Behalf of the Acquired Fund** 

JHVIT on behalf of the Acquired Fund covenants to the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) *Meeting of the Acquired Fund's Shareholders*. JHVIT shall call and hold a meeting of the shareholders of the Acquired Fund for the purpose of acting upon this Plan and the transactions contemplated herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) *Portfolio Securities*. With respect to the assets to be transferred in accordance with Section 1(a), the Acquired Fund's assets shall consist of all property and assets of any nature whatsoever, including, without limitation, all cash, cash equivalents, securities, claims and receivables (including dividend and interest receivables) owned, and any deferred or prepaid expenses shown as an asset on the Acquired Fund's books. At least five (5)

------

##### [**Table of Contents**](#toc)
business days prior to the Exchange Date, the Acquired Fund will provide the Acquiring Fund with a list of its assets and a list of its stated liabilities. The Acquired Fund shall have the right to sell any of the securities or other assets shown on the list of assets prior to the Exchange Date but will not, without the prior approval of JHVIT, on behalf of the Acquiring Fund, acquire any additional securities other than securities that the Acquiring Fund is permitted to purchase, pursuant to its investment objective and policies or otherwise (taking into consideration its own portfolio composition as of such date). In the event that the Acquired Fund holds any investments that the Acquiring Fund would not be permitted to hold, the Acquired Fund will dispose of such securities prior to the Exchange Date to the extent practicable and to the extent that its shareholders would not be materially affected in an adverse manner by such a disposition. In addition, JHVIT will prepare and deliver, on the Exchange Date, immediately prior to the Effective Time of the Reorganization, a Statement of Assets and Liabilities of the Acquired Fund as of the Effective Time of the Reorganization and prepared in accordance with GAAP (the "Schedule"). All securities to be listed in the Schedule for the Acquired Fund as of the Effective Time of the Reorganization will be owned by the Acquired Fund free and clear of any liens, claims, charges, options and encumbrances, except as indicated in the Schedule, and, except as so indicated, none of such securities is or, after the Reorganization as contemplated hereby, will be subject to any restrictions, legal or contractual, on the disposition thereof (including restrictions as to the public offering or sale thereof under the Securities Act) and, except as so indicated, all such securities are or will be readily marketable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) *Registration Statement*. In connection with the preparation of the Registration Statement, JHVIT on behalf of the Acquired Fund will furnish the information relating to the Acquired Fund required by the Securities Act and the Regulations to be set forth in the Registration Statement (including the Prospectus and SAI). At the time the Registration Statement becomes effective, the Registration Statement, insofar as it relates to the Acquired Fund: (i) will comply in all material respects with the provisions of the Securities Act and the Regulations; and (ii) will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; and at the time the Registration Statement becomes effective, at the time of the Acquired Fund's shareholders meeting referred to in Section 5(a) and at the Effective Time of the Reorganization, the Prospectus and SAI, as amended or supplemented by any amendments or supplements filed by JHVIT, insofar as they relate to the Acquired Fund, will not contain an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that the representations and warranties in this subsection shall apply only to statements in or omissions from the Registration Statement, Prospectus or SAI made in reliance upon and in conformity with information furnished by JHVIT with respect to the Acquired Fund for use in the Registration Statement, Prospectus or SAI as provided in this Section 5(c).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) *Cooperation in Effecting Reorganization*. JHVIT on behalf of the Acquired Fund agrees to use all reasonable efforts to effectuate the Reorganization and to obtain any necessary regulatory approvals for the Reorganization.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) *Operations in the Ordinary Course*. Except as otherwise contemplated by this Plan, and, in particular, any actions necessary as a result of the circumstances identified in Section 1(a)(ii) of this Plan, JHVIT with respect to the Acquired Fund shall conduct its business in the ordinary course until the consummation of the Reorganization, it being understood that such ordinary course of business will include the declaration and payment of customary dividends and distributions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) *Statement of Earnings and Profits*. As promptly as practicable, but in any case within 60 days after the Exchange Date, JHVIT on behalf of the Acquired Fund shall prepare a statement of the earnings and profits of the Acquired Fund for federal income tax purposes, and of any capital loss carryovers and other items that the Acquiring Fund will succeed to and take into account as a result of Section 381 of the Code (if any).

**6. Conditions Precedent to Obligations of JHVIT on Behalf of the Acquired Fund** 

The obligations of JHVIT on behalf of the Acquired Fund with respect to the consummation of the Reorganization are subject to the satisfaction of the following conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) *Approval by the Acquired Fund's Shareholders*. This Plan and the transactions contemplated by the Reorganization shall have been approved by the requisite vote of the shares of the Acquired Fund entitled to vote on the matter ("Acquired Shareholder Approval").

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) *Covenants, Warranties and Representations*. With respect to the Acquiring Fund, JHVIT shall have complied with each of its covenants contained herein, each of the representations and warranties contained herein shall be true in all material respects as of the Effective Time of the Reorganization (except as otherwise contemplated herein), and there shall have been no material adverse change (as described in Section 2(i)) in the financial condition, results of operations, business, properties or assets of the Acquiring Fund since December 31, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) *Regulatory Approval*. The Registration Statement shall have been declared effective by the Commission and no stop orders under the Securities Act pertaining thereto shall have been issued and all other approvals, registrations, and exemptions under federal and state laws considered to be necessary shall have been obtained (collectively, the "Regulatory Approvals").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) *Tax Opinions*. JHVIT shall have received one or more opinions of K&L Gates LLP, dated on or before the Effective Time of the Reorganization, addressed to and in form and substance satisfactory to JHVIT, that, assuming the variable contracts and the insurance companies issuing them are properly structured under the insurance company provisions of the Code, the Reorganization will not be a taxable event for contract owners whose contract values are determined by investment in shares of the Acquired Fund (the "Tax Opinions"). For purposes of rendering its opinion, K&L Gates LLP may rely exclusively and without independent verification, as to factual matters, on the statements made in the Plan, the Prospectus and SAI, and on such other written representations verified as of the Effective Time of the Reorganization.

**7. Conditions Precedent to Obligations of JHVIT on Behalf of the Acquiring Fund** 

The obligations of JHVIT on behalf of the Acquiring Fund with respect to the consummation of the Reorganization are subject to the satisfaction of the following conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) *Approval by the Acquired Fund's Shareholders*. The Acquired Shareholder Approval shall have been obtained with respect to the Acquired Fund.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) *Covenants, Warranties and Representations*. With respect to the Acquired Fund, JHVIT shall have complied with each of its covenants contained herein, each of the representations and warranties contained herein shall be true in all material respects as of the Effective Time of the Reorganization (except as otherwise contemplated herein), and there shall have been no material adverse change (as described in Section 3(h)) in the financial condition, results of operations, business, properties or assets of the Acquired Fund since December 31, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) *Portfolio Securities*. All securities to be acquired by the Acquiring Fund in the Reorganization shall have been approved for acquisition by JHVTA (or, at its discretion, by a subadvisor for the Acquiring Fund) as consistent with the investment policies of the Acquiring Fund.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) *Regulatory Approval*. The Regulatory Approvals shall have been obtained.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) *Distribution of Income and Gains*. JHVIT on behalf of the Acquired Fund shall have distributed to the shareholders of the Acquired Fund all of the Acquired Fund's investment company taxable income (without regard to the deductions for dividends paid) as defined in Section 852(b)(2) of the Code for its taxable year ending on the Exchange Date and all of its net capital gain as such term is used in Section 852(b)(3) of the Code, after reduction by any capital loss carry forward, for its taxable year ending on the Exchange Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) *Tax Opinions*. JHVIT shall have received the Tax Opinions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) *Financial Statements*. The financial statements of JHVIT for the fiscal year ended December 31, 2024 shall have been audited by the independent registered public accounting firm retained by JHVIT. In addition, as of the Exchange Date and except as may be affected by the transactions contemplated by this Plan: (i) the representations and warranties of JHVIT on behalf of the Acquired Fund set forth in Sections 3(e) and (g) of this Plan are true and correct as to the financial statements referred to in the first sentence of this Section 7(g); and (ii) the representation and warranty set forth in the first sentence of Section 3(k) of this Plan are true and correct as to all taxable years up to and including December 31, 20.

------

##### [**Table of Contents**](#toc)
**8. Amendments; Terminations; No Survival of Covenants, Warranties and Representations** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) *Amendments*. JHVIT may, by an instrument in writing authorized by the Board, amend this Plan at any time before or after approval hereof by the shareholders of the Acquired Fund, but after such approval, no amendment shall be made that substantially changes the terms hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) *Waivers*. At any time prior to the Effective Time of the Reorganization, JHVIT, on behalf of either or both of the Acquired and Acquiring Funds, may by written instrument signed by it; (i) waive any inaccuracies in the representations and warranties made to it or such Fund or series contained herein; and (ii) waive compliance with any of the covenants or conditions made for its benefit or the benefit of such Fund or series contained herein, except that conditions set forth in Sections 6(c) and 7(d) may not be waived.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) *Termination*. This Plan may be terminated by JHVIT at any time prior to the Effective Time of the Reorganization, whether before or after approval of this Plan by the shareholders of the Acquired Fund, without liability on the part of any party hereto, its Trustees, officers or shareholders, in the event that either the Board or one or more of the officers of JHVIT determine that proceeding with this Plan is not in the best interests of the shareholders or contract owners of either or both of the Acquired and Acquiring Funds, or for any other reason.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Unless JHVIT shall otherwise determine by written instrument, this Plan shall terminate without liability as of the close of business on November 1, 2026 if the Effective Time of the Reorganization is not on or prior to such date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) *Survival*. No representations, warranties or covenants in or pursuant to this Plan, except for the provisions of Section 5(f) and Section 9 of this Plan, shall survive the Reorganization.

**9. Expenses** 

The projected expenses of the Reorganization are $198,773, of which $182,626 will be borne by the Acquired Fund (amounting to four basis points and less than $0.01 per share) and $16,147 will be borne by the Acquiring Fund (amounting to less than one basis point and less than $0.01 per share). If the Reorganization is not consummated, the expenses of the Reorganization as to that Acquired Fund or the Acquiring Fund, as applicable, will be paid by JHVTA. Such expenses include, without limitation: (i) expenses incurred in connection with the entering into and the carrying out of the provisions of this Plan; (ii) expenses associated with the preparation and filing of the Registration Statement (other than registration fees payable to the Commission in respect of the registration of the Acquiring Fund shares registered thereby, which shall be payable by the Acquiring Fund); (iii) fees and expenses of preparing and filing such forms as are necessary under any applicable state securities laws in connection with the Reorganization; (iv) postage; (v) printing; (vi) accounting fees; (vii) legal fees; and (viii) solicitation costs relating to the Reorganization.

**10. Reliance** 

All covenants and agreements made under this Plan shall be deemed to have been material and relied upon by the Acquired Fund, the Acquiring Fund and JHVIT notwithstanding any investigation made by such party or on its behalf.

**11. Headings; Counterparts; Governing Law; Assignment** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The section and paragraph headings contained in this Plan are for reference purposes only and shall not affect in any way the meaning or interpretation of this Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) This Plan may be executed in any number of counterparts, each of which shall be deemed an original.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) This Plan shall be governed by and construed in accordance with the laws of The Commonwealth of Massachusetts.

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) This Plan shall bind and inure to the benefit of JHVIT, the Acquired Fund and the Acquiring Fund and their respective successors and assigns, but no assignment or transfer hereof or of any rights or obligations hereunder shall be made by any party without the written consent of the other parties. Nothing herein expressed or implied is intended or shall be construed to confer upon or give any person, firm or corporation, other than the parties hereto and their respective successors and assigns, any rights or remedies under or by reason of this Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) The name "John Hancock Variable Insurance Trust" is the designation of the Trustees under an Agreement and Declaration of Trust dated January 22, 2016, as amended, and all persons dealing with JHVIT must look solely to JHVIT's property for the enforcement of any claims against JHVIT, as neither the Trustees, officers, agents or shareholders assume any personal liability for obligations entered into on behalf of JHVIT. No series of JHVIT shall be liable for claims against any other series of JHVIT.

**IN WITNESS WHEREOF**, the undersigned have executed this Plan as of the date first above written.

---

| | |
|:---|:---|
| JOHN HANCOCK VARIABLE INSURANCE TRUST,<br> on behalf of the Acquired Fund | JOHN HANCOCK VARIABLE INSURANCE TRUST,<br> on behalf of the Acquired Fund |
|  BY: | |
|  | Name: |
|  | Title: |

---

---

| | |
|:---|:---|
| JOHN HANCOCK VARIABLE INSURANCE TRUST,<br> on behalf of the Acquiring Fund | JOHN HANCOCK VARIABLE INSURANCE TRUST,<br> on behalf of the Acquiring Fund |
|  BY: | |
|  | Name: |
|  | Title: |

---

---

| | |
|:---|:---|
| For purposes of Section 9 only:<br>JOHN HANCOCK VARIABLE TRUST ADVISERS LLC | For purposes of Section 9 only:<br>JOHN HANCOCK VARIABLE TRUST ADVISERS LLC |
|  BY: | |
|  | Name: |
|  | Title: |

---

------

##### [**Table of Contents**](#toc)
**Appendix B** 

**FINANCIAL HIGHLIGHTS OF THE FUNDS** 

The financial highlights tables for the Acquired and Acquiring Fund are intended to help investors understand the financial performance of each Fund for the past five years ended December 31, 2024 and the six month period ended June 30, 2025. Certain information reflects financial results for a single share of a fund. The total returns presented in the table represent the rate that an investor would have earned (or lost) on an investment in the particular fund (assuming reinvestment of all dividends and distributions). The financial statements of JHVIT included in its Annual Report to Shareholders for the fiscal year ended December 31, 2024 (File Nos. 2-94157 and 811-04146) have been audited by PricewaterhouseCoopers LLP. These financial statements have been incorporated by reference into the SAI insofar as they relate to the Acquired and Acquiring Funds. Copies of the Annual Report are available on request as described above.

The performance information included in the "Financial Highlights" does not reflect fees and expenses of any variable insurance contract that may use JHVIT as its underlying investment medium. If such fees and expenses had been reflected, performance would be lower.

------

##### [**Table of Contents**](#toc)
American International Trust

---

| | | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Per share operating performance for a share outstanding throughout each period** | **Per share operating performance for a share outstanding throughout each period** | **Per share operating performance for a share outstanding throughout each period** | **Per share operating performance for a share outstanding throughout each period** | **Per share operating performance for a share outstanding throughout each period** | **Per share operating performance for a share outstanding throughout each period** | **Per share operating performance for a share outstanding throughout each period** | **Per share operating performance for a share outstanding throughout each period** | **Per share operating performance for a share outstanding throughout each period** | **Per share operating performance for a share outstanding throughout each period** | **Per share operating performance for a share outstanding throughout each period** | **Ratios and supplemental data** | **Ratios and supplemental data** | **Ratios and supplemental data** | **Ratios and supplemental data** | **Ratios and supplemental data** |
|  | | **Income (loss) from <br>investment operations** | **Income (loss) from <br>investment operations** | | **Less distributions** | **Less distributions** | **Less distributions** | **Less distributions** | | | **Ratios to average net assets** | **Ratios to average net assets** | **Ratios to average net assets** | | |
| Period <br>ended | Net asset<br>value,<br>beginning<br>of period<br>($) | Net<br>investment<br>income<br>(loss)<br>($)<sup>1</sup> | Net<br>realized<br>and<br>unrealized<br>gain<br>(loss)<br>on invest-<br>ments<br>($) | Total<br>from<br>investment<br>operations<br>($) | From net<br>investment<br>income<br>($) | From<br>net<br>realized<br>gain<br>($) | From<br>tax<br>return<br>of<br>capital<br>($) | Total<br>distribu-<br>tions<br>($) | Net asset<br>value,<br>end<br>of period<br>($) | Total<br>return<br>(%)<sup>2</sup> | Expenses<br>before<br>reductions<br>(%) | Expenses<br>including<br>reduc-<br>tions<br>(%) | Net<br>investment<br>income<br>(loss)<br>(%) | Net<br>assets,<br>end of<br>period<br>(in<br>millions) | Portfolio<br>turnover<br>(%) |
|  **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** |
| 06-30-2025<sup>3</sup> | 14.77 | (0.04)<sup>4</sup> | 1.78 | 1.74 |  |  |  |  | 16.51 | 11.78<sup>5</sup> | 0.64<sup>6,7</sup> | 0.63<sup>6,7</sup> | (0.50)<sup>4,6</sup> | 139 | 1 |
| 12-31-2024 | 14.50 | 0.12<sup>4</sup> | 0.29 | 0.41 | (0.12) | (0.02) |  | (0.14) | 14.77 | 2.79 | 0.64<sup>7</sup> | 0.63<sup>7</sup> | 0.80<sup>4</sup> | 122 | 6 |
| 12-31-2023 | 15.03 | 0.15<sup>4</sup> | 1.87 | 2.02 | (0.15) | (2.40) |  | (2.55) | 14.50 | 15.39 | 0.65<sup>7</sup> | 0.64<sup>7</sup> | 0.93<sup>4</sup> | 122 | 7 |
| 12-31-2022 | 20.56 | 0.22<sup>4</sup> | (4.63) | (4.41) | (0.22) | (0.90) |  | (1.12) | 15.03 | (21.11) | 0.64<sup>7</sup> | 0.63<sup>7</sup> | 1.32<sup>4</sup> | 106 | 15 |
| 12-31-2021 | 21.41 | 0.41<sup>4</sup> | (0.80) | (0.39) | (0.42) | (0.04) |  | (0.46) | 20.56 | (1.81) | 0.63<sup>7</sup> | 0.63<sup>7</sup> | 1.89<sup>4</sup> | 145 | 9 |
| 12-31-2020 | 19.83 | 0.06<sup>4</sup> | 2.46 | 2.52 | (0.07) | (0.87) |  | (0.94) | 21.41 | 13.56 | 0.64<sup>7</sup> | 0.63<sup>7</sup> | 0.32<sup>4</sup> | 170 | 10 |
|  **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** |
| 06-30-2025<sup>3</sup> | 14.76 | (0.05)<sup>4</sup> | 1.79 | 1.74 |  |  |  |  | 16.50 | 11.79<sup>5</sup> | 0.79<sup>6,7</sup> | 0.73<sup>6,7</sup> | (0.60)<sup>4,6</sup> | 204 | 1 |
| 12-31-2024 | 14.50 | 0.10<sup>4</sup> | 0.28 | 0.38 | (0.10) | (0.02) |  | (0.12) | 14.76 | 2.61 | 0.79<sup>7</sup> | 0.75<sup>7</sup> | 0.62<sup>4</sup> | 201 | 6 |
| 12-31-2023 | 15.03 | 0.12<sup>4</sup> | 1.87 | 1.99 | (0.12) | (2.40) |  | (2.52) | 14.50 | 15.23 | 0.80<sup>7</sup> | 0.77<sup>7</sup> | 0.75<sup>4</sup> | 213 | 7 |
| 12-31-2022 | 20.54 | 0.20<sup>4</sup> | (4.61) | (4.41) | (0.20) | (0.90) |  | (1.10) | 15.03 | (21.16) | 0.79<sup>7</sup> | 0.76<sup>7</sup> | 1.20<sup>4</sup> | 206 | 15 |
| 12-31-2021 | 21.39 | 0.39<sup>4</sup> | (0.81) | (0.42) | (0.39) | (0.04) |  | (0.43) | 20.54 | (1.96) | 0.78<sup>7</sup> | 0.76<sup>7</sup> | 1.80<sup>4</sup> | 293 | 9 |
| 12-31-2020 | 19.82 | 0.03<sup>4</sup> | 2.46 | 2.49 | (0.05) | (0.87) |  | (0.92) | 21.39 | 13.40 | 0.79<sup>7</sup> | 0.76<sup>7</sup> | 0.16<sup>4</sup> | 317 | 10 |
|  **<u>Series III</u>** | **<u>Series III</u>** | **<u>Series III</u>** | **<u>Series III</u>** | **<u>Series III</u>** | **<u>Series III</u>** | **<u>Series III</u>** | **<u>Series III</u>** | **<u>Series III</u>** | **<u>Series III</u>** | **<u>Series III</u>** | **<u>Series III</u>** | **<u>Series III</u>** | **<u>Series III</u>** | **<u>Series III</u>** | **<u>Series III</u>** |
| 06-30-2025<sup>3</sup> | 14.69 | (0.01)<sup>4</sup> | 1.78 | 1.77 |  |  |  |  | 16.46 | 12.05<sup>5</sup> | 0.29<sup>6,7</sup> | 0.28<sup>6,7</sup> | (0.15)<sup>4,6</sup> | 27 | 1 |
| 12-31-2024 | 14.43 | 0.17<sup>4</sup> | 0.28 | 0.45 | (0.17) | (0.02) |  | (0.19) | 14.69 | 3.10 | 0.29<sup>7</sup> | 0.28<sup>7</sup> | 1.08<sup>4</sup> | 26 | 6 |
| 12-31-2023 | 14.97 | 0.20<sup>4</sup> | 1.86 | 2.06 | (0.20) | (2.40) |  | (2.60) | 14.43 | 15.76 | 0.30<sup>7</sup> | 0.29<sup>7</sup> | 1.24<sup>4</sup> | 28 | 7 |
| 12-31-2022 | 20.48 | 0.29<sup>4</sup> | (4.62) | (4.33) | (0.28) | (0.90) |  | (1.18) | 14.97 | (20.80) | 0.29<sup>7</sup> | 0.28<sup>7</sup> | 1.72<sup>4</sup> | 27 | 15 |
| 12-31-2021 | 21.34 | 0.50<sup>4</sup> | (0.82) | (0.32) | (0.50) | (0.04) |  | (0.54) | 20.48 | (1.50) | 0.28<sup>7</sup> | 0.28<sup>7</sup> | 2.31<sup>4</sup> | 36 | 9 |
| 12-31-2020 | 19.75 | 0.12<sup>4</sup> | 2.47 | 2.59 | (0.13) | (0.87) |  | (1.00) | 21.34 | 13.98 | 0.29<sup>7</sup> | 0.28<sup>7</sup> | 0.64<sup>4</sup> | 38 | 10 |

---

---

| | |
|:---|:---|
| **1** | Based on average daily shares outstanding.  |

---

---

| | |
|:---|:---|
| **2** | Total returns exclude insurance-related fees and expenses and would have been lower had certain expenses not been reduced during the applicable periods  |

---

---

| | |
|:---|:---|
| **3** | Six months ended 6-30-25. Unaudited.  |

---

---

| | |
|:---|:---|
| **4** | Net investment income is affected by the timing and frequency of the declaration of dividends by the underlying funds in which the portfolio invests.  |

---

---

| | |
|:---|:---|
| **5** | Not annualized.  |

---

---

| | |
|:---|:---|
| **6** | Annualized.  |

---

---

| | |
|:---|:---|
| **7** | Ratios do not include expenses indirectly incurred from underlying funds and can vary based on the mix of underlying funds held by the portfolio.  |

---

------

##### [**Table of Contents**](#toc)
Disciplined Value International Trust

---

| | | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Per share operating performance for a share outstanding throughout each period** | **Per share operating performance for a share outstanding throughout each period** | **Per share operating performance for a share outstanding throughout each period** | **Per share operating performance for a share outstanding throughout each period** | **Per share operating performance for a share outstanding throughout each period** | **Per share operating performance for a share outstanding throughout each period** | **Per share operating performance for a share outstanding throughout each period** | **Per share operating performance for a share outstanding throughout each period** | **Per share operating performance for a share outstanding throughout each period** | **Per share operating performance for a share outstanding throughout each period** | **Per share operating performance for a share outstanding throughout each period** | **Ratios and supplemental data** | **Ratios and supplemental data** | **Ratios and supplemental data** | **Ratios and supplemental data** | **Ratios and supplemental data** |
|  | | **Income (loss) from <br>investment operations** | **Income (loss) from <br>investment operations** | | **Less distributions** | **Less distributions** | **Less distributions** | **Less distributions** | | | **Ratios to average net assets** | **Ratios to average net assets** | **Ratios to average net assets** | | |
| Period <br>ended | Net asset<br>value,<br>beginning<br>of period<br>($) | Net<br>investment<br>income<br>(loss)<br>($)<sup>1</sup> | Net<br>realized<br>and<br>unrealized<br>gain<br>(loss)<br>on invest-<br>ments<br>($) | Total<br>from<br>investment<br>operations<br>($) | From net<br>investment<br>income<br>($) | From<br>net<br>realized<br>gain<br>($) | From<br>tax<br>return<br>of<br>capital<br>($) | Total<br>distribu-<br>tions<br>($) | Net asset<br>value,<br>end<br>of period<br>($) | Total<br>return<br>(%)<sup>2</sup> | Expenses<br>before<br>reductions<br>(%) | Expenses<br>including<br>reduc-<br>tions<br>(%) | Net<br>investment<br>income<br>(loss)<br>(%) | Net<br>assets,<br>end of<br>period<br>(in<br>millions) | Portfolio<br>turnover<br>(%) |
|  **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** | **<u>Series I</u>** |
| 06-30-2025<sup>3</sup> | 13.99 | 0.24 | 3.47 | 3.71 |  |  |  |  | 17.70 | 26.52<sup>4</sup> | 0.85<sup>5</sup> | 0.85<sup>5</sup> | 3.07<sup>5</sup> | 81 | 36 |
| 12-31-2024 | 15.47 | 0.31 | (0.24) | 0.07 | (0.05) | (1.50) |  | (1.55) | 13.99 | (0.38) | 0.84 | 0.84 | 1.95 | 68 | 93 |
| 12-31-2023 | 13.15 | 0.32 | 2.28 | 2.60 | (0.28) |  |  | (0.28) | 15.47 | 19.96 | 0.87 | 0.86 | 2.22 | 77 | 81 |
| 12-31-2022 | 14.38 | 0.31 | (1.05) | (0.74) | (0.49) |  |  | (0.49) | 13.15 | (4.77) | 0.93 | 0.92 | 2.33 | 67 | 74 |
| 12-31-2021 | 13.05 | 0.46 | 1.25 | 1.71 | (0.38) |  |  | (0.38) | 14.38 | 13.06 | 0.93 | 0.92 | 3.21 | 78 | 60 |
| 12-31-2020 | 12.92 | 0.21 | 0.17 | 0.38 | (0.25) |  |  | (0.25) | 13.05 | 3.27 | 0.94 | 0.94 | 1.85 | 77 | 1906 |
|  **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** | **<u>Series II</u>** |
| 06-30-2025<sup>3</sup> | 13.97 | 0.22 | 3.47 | 3.69 |  |  |  |  | 17.66 | 26.41<sup>4</sup> | 1.05<sup>5</sup> | 1.05<sup>5</sup> | 2.86<sup>5</sup> | 47 | 36 |
| 12-31-2024 | 15.45 | 0.28 | (0.24) | 0.04 | (0.02) | (1.50) |  | (1.52) | 13.97 | (0.56) | 1.04 | 1.04 | 1.75 | 40 | 93 |
| 12-31-2023 | 13.14 | 0.29 | 2.27 | 2.56 | (0.25) |  |  | (0.25) | 15.45 | 19.69 | 1.07 | 1.06 | 2.02 | 45 | 81 |
| 12-31-2022 | 14.37 | 0.29 | (1.06) | (0.77) | (0.46) |  |  | (0.46) | 13.14 | (4.98) | 1.13 | 1.12 | 2.15 | 41 | 74 |
| 12-31-2021 | 13.04 | 0.43 | 1.25 | 1.68 | (0.35) |  |  | (0.35) | 14.37 | 12.86 | 1.13 | 1.12 | 3.02 | 46 | 60 |
| 12-31-2020 | 12.91 | 0.19 | 0.17 | 0.36 | (0.23) |  |  | (0.23) | 13.04 | 3.07 | 1.14 | 1.14 | 1.65 | 46 | 1906 |
|  **<u>Series NAV</u>** | **<u>Series NAV</u>** | **<u>Series NAV</u>** | **<u>Series NAV</u>** | **<u>Series NAV</u>** | **<u>Series NAV</u>** | **<u>Series NAV</u>** | **<u>Series NAV</u>** | **<u>Series NAV</u>** | **<u>Series NAV</u>** | **<u>Series NAV</u>** | **<u>Series NAV</u>** | **<u>Series NAV</u>** | **<u>Series NAV</u>** | **<u>Series NAV</u>** | **<u>Series NAV</u>** |
| 06-30-2025<sup>3</sup> | 13.85 | 0.24 | 3.44 | 3.68 |  |  |  |  | 17.53 | 26.57<sup>4</sup> | 0.80<sup>5</sup> | 0.80<sup>5</sup> | 3.09<sup>5</sup> | 174 | 36 |
| 12-31-2024 | 15.33 | 0.31 | (0.23) | 0.08 | (0.06) | (1.50) |  | (1.56) | 13.85 | (0.35) | 0.79 | 0.79 | 1.98 | 156 | 93 |
| 12-31-2023 | 13.03 | 0.33 | 2.25 | 2.58 | (0.28) |  |  | (0.28) | 15.33 | 20.05 | 0.82 | 0.81 | 2.27 | 161 | 81 |
| 12-31-2022 | 14.26 | 0.31 | (1.04) | (0.73) | (0.50) |  |  | (0.50) | 13.03 | (4.75) | 0.88 | 0.87 | 2.35 | 151 | 74 |
| 12-31-2021 | 12.94 | 0.46 | 1.24 | 1.70 | (0.38) |  |  | (0.38) | 14.26 | 13.15 | 0.88 | 0.87 | 3.26 | 193 | 60 |
| 12-31-2020 | 12.82 | 0.21 | 0.16 | 0.37 | (0.25) |  |  | (0.25) | 12.94 | 3.27 | 0.89 | 0.89 | 1.90 | 178 | 1906 |

---

---

| | |
|:---|:---|
| **1** | Based on average daily shares outstanding.  |

---

---

| | |
|:---|:---|
| **2** | Total returns exclude insurance-related fees and expenses and would have been lower had certain expenses not been reduced during the applicable periods  |

---

---

| | |
|:---|:---|
| **3** | Six months ended 6-30-25. Unaudited.  |

---

---

| | |
|:---|:---|
| **4** | Not annualized.  |

---

---

| | |
|:---|:---|
| **5** | Annualized.  |

---

---

| | |
|:---|:---|
| **6** | Increase in portfolio turnover rate resulted from repositioning of the portfolio during the period in accordance with investment policy changes approved by the Board of Trustees.  |

---

------

##### [**Table of Contents**](#toc)
JOHN HANCOCK VARIABLE INSURANCE TRUST

P.O. BOX 9112

FARMINGDALE, NY 11735

---

| |
|:---|
| VOTE BY PHONE |
| Read the Proxy Statement/Prospectus and have this card at hand – Read the Proxy Statement/Prospectus and have this card at hand – Read the Proxy Statement/Prospectus and have this card at hand |
| Call toll-free 1-800-690-6903 – Log on to www.proxyvote.com – Check the appropriate boxes on reverse side |
| Follow the recorded instructions – Follow the on-screen instructions – Sign and date Voting Instructions |
| Do not return this paper ballot – Do not return this paper ballot – Return promptly in the enclosed envelope |

---

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

VOTING INSTRUCTIONS FORM

AMERICAN INTERNATIONAL TRUST

INSURANCE COMPANY NAME PRINTS HERE

The undersigned hereby instructs John Hancock Life Insurance Company (U.S.A.) and John Hancock Life Insurance Company of New York to vote all shares of American International Trust (the "Fund") attributable to his or her variable annuity or variable life contract at the Special Meeting of Shareholders to be held at 200 Berkeley Street, Boston, Massachusetts 02116 at **10:00 a.m.**, Eastern Time, April 7, 2026, and any adjournments thereof, as indicated below and in their discretion upon such other matters as may properly come before the Meeting.

Voting pursuant to these instructions will be as specified. If no specification is made as to an item on a properly executed Voting Instructions Form, voting will be for such item. This voting instructions form is provided for the shares of the above referenced fund attributable to your contract values as of February 6. 2026. Please sign, date, and return the voting instructions form in the enclosed postage-paid envelope.

VOTING INSTRUCTIONS MUST BE RECEIVED BY THE CLOSE OF BUSINESS ON APRIL 6, 2026 TO BE VOTED AT THE MEETING TO BE HELD ON APRIL 7, 2026.

THESE VOTING INSTRUCTIONS ARE SOLICITED BY JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) AND JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK IN CONNECTION WITH THE SOLICITATION OF PROXIES BY THE BOARD OF TRUSTEES OF JOHN HANCOCK VARIABLE INSURANCE TRUST.

---

| |
|:---|
| (ARROW) |
| Date: , 2026 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>PLEASE SIGN IN BOX</u> BELOW: |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Signature(s), Title(s), if applicable |

---

If a contract is held jointly, each contract owner should sign. If only one signs his or her signature will be binding. If the contract owner is a corporation, the President or a Vice President should sign in his or her own name, indicating title. If the contract owner is a partnership, a partner should sign his or her own name, indicating that he or she is a "Partner." If the contract owner is a trust, the trustee should sign in his or her own name, indicating that he or she is a "Trustee."

------

##### [**Table of Contents**](#toc)

---

| | |
|:---|:---|
| (ARROW) | PLEASE FILL IN BOX AS SHOWN USING BLACK OR BLUE INK OR ☒ (ARROW) |
|  | NUMBER 2 PENCIL. |
|  | PLEASE DO NOT USE FINE POINT PENS. |

---

These voting instructions, if properly executed, will be voted in the manner directed by the contract owner. IF NO DIRECTION IS MADE, THESE VOTING INSTRUCTIONS WILL BE VOTED "FOR" THE PROPOSAL. Please refer to the Proxy Statement/Prospectus for a discussion of the proposal.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  | FOR | AGAINST | ABSTAIN |
| Proposal | Approval of Agreement and Plan of Reorganization providing for the reorganization of the Fund into Disciplined Value International Trust. Under this agreement, the Fund would transfer all of its assets to the Acquiring Fund in exchange for corresponding shares of the Acquiring Fund. These shares would be distributed, as described in the accompanying proxy statement and prospectus. The Acquiring Fund would also assume all of the Fund's liabilities. | ☐ | ☐ | ☐ |

---

PLEASE SIGN AND DATE ON THE REVERSE SIDE.

------

##### [**Table of Contents**](#toc)

---

| | | |
|:---|:---|:---|
| **PROXY** | **AMERICAN INTERNATIONAL TRUST** | **PROXY** |

---

**PROXY FOR A SPECIAL MEETING OF SHAREHOLDERS TO BE HELD APRIL 6, 2021** 

**THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF JOHN HANCOCK VARIABLE INSURANCE TRUST** 

The undersigned revoking previous proxies, hereby appoint(s) Erica Blake, Thomas Dee, Khimmara Greer, Kinga Kapuscinski, Nicholas J. Kolokithas, Mara C.S. Moldwin, Harsha Pulluru, Christopher Sechler, Betsy Anne Seel, Steven Sunnerberg, Fernando Silva, Salvatore Schiavone, Jay Aronowitz, and Phil Fontana, with full power of substitution in each, to vote all the shares of beneficial interest of American International Trust ("the Fund"), a series of John Hancock Variable Insurance Trust ("JHVIT") which the undersigned is (are) entitled to vote at the Special Meeting of Shareholders of JHVIT (the "Meeting") to be held at 200 Berkeley Street, Boston, Massachusetts 02116, on Tuesday, April 7, 2026, at 10:00 a.m., Eastern Time, and at any adjournment(s) of the Meeting. All powers may be exercised by a majority of all proxy holders or substitutes voting or acting, or, if only one votes and acts, then by that one. Receipt of the Proxy Statement and Prospectus dated February [27], 2026, is hereby acknowledged. If not revoked, this proxy shall be voted for the proposals included in the Proxy Statement and Prospectus.

**VOTE VIA THE INTERNET: N/A** 

**VOTE VIA THE TELEPHONE: N/A** 

**VOTE VIA MAIL: Vote, date and sign this proxy card and return it promptly in the enclosed envelope.** 

 **999 9999 9999 999**

**Note:** Signature(s) should agree with the name (s) printed herein. When signing as attorney, executor, administrator, trustee or guardian, please give your full name as such. If a corporation, please sign in full corporate name by president or other authorized officer. If a partnership, please sign in partnership name by authorized person.

---

| |
|:---|
| JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) |
| JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK |
| By: |

---

 <br> Name:    

 <br> Title:    

 <br> Date:    

------

##### [**Table of Contents**](#toc)
**EVERY SHAREHOLDER'S VOTE IS IMPORTANT** 

***PLEASE SIGN, DATE AND RETURN YOUR PROXY TODAY***

Please detach at perforation before mailing.

SPECIFY YOUR DESIRED ACTION BY A CHECK MARK IN THE APPROPRIATE SPACE. THIS PROXY WILL BE VOTED IN FAVOR OF (FOR) THE PROPOSAL IF NO SPECIFICATION IS MADE BELOW. AS TO ANY OTHER MATTER, THE PROXY OR PROXIES WILL VOTE IN ACCORDANCE WITH THEIR BEST JUDGMENT.

---

| | | | |
|:---|:---|:---|:---|
| **TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK. Example:** ∎ |  |  |  |
|  | ☐ FOR | ☐ AGAINST | ☐ ABSTAIN |
| To approve an Agreement and Plan of Reorganization providing for the reorganization of American International Trust (the "Acquired Fund") into Disciplined Value International Trust (the "Acquiring Fund"), each a series of the Trust. Under this agreement, the Acquired Fund would transfer all of its assets to the Acquiring Fund in exchange for shares of the Acquiring Fund. These shares would be distributed, as described in the accompanying Proxy Statement/Prospectus, proportionately to you and the other shareholders of the Acquired Fund. The direct costs of the Reorganization will be borne by the Acquired Fund. The Acquiring Fund would also assume substantially all of the Acquired Fund's liabilities. |  |  |  |

---

**Important Notice Regarding Availability of Proxy Materials for this Meeting to Be Held on September 23, 2020** 

**PLEASE VOTE, DATE AND SIGN THIS PROXY CARD AND RETURN IT PROMPTLY IN THE ENCLOSED ENVELOPE** 

------

##### [**Table of Contents**](#toc)
**STATEMENT OF ADDITIONAL INFORMATION** 

Dated: [February ], 2026

AMERICAN INTERNATIONAL TRUST

(the "Acquired Fund," a series of John Hancock Variable Insurance Trust)

AND

DISCIPLINED VALUE INTERNATIONAL TRUST

(the "Acquiring Fund," a series of John Hancock Variable Insurance Trust)

This Statement of Additional Information ("SAI") is not a prospectus. It should be read in conjunction with the related combined Proxy Statement/Prospectus (also dated [February ], 2026). This SAI provides additional information about the Acquired Fund and the Acquiring Fund (the "Funds"). Please retain this SAI for further reference.

This SAI is intended to supplement the information provided in the combined Proxy Statement/Prospectus dated [February ], 2026, relating to the proposed reorganization of the Acquired Fund into the Acquiring Fund (the "Reorganization") and in connection with the solicitation by the Acquired Fund of proxies to be voted at the Special Meeting of Shareholders of the Acquired Fund to be held on April 7, 2026.

The Proxy Statement/Prospectus may be obtained free of charge by writing or telephoning:

JOHN HANCOCK VARIABLE INSURANCE TRUST

200 Berkeley Street

Boston, Massachusetts 02116

800-344-1029

Shareholders will receive a copy of each document that is incorporated by reference upon any request to receive a copy of this SAI.

**TABLE OF CONTENTS** 

The Statement of Additional Information of John Hancock Variable Insurance Trust ("JHVIT") dated April 28, 2025 (the "JHVIT SAI") relating to the Acquired Fund and the Acquiring Fund.

[Audited Financial Statements of JHVIT for the fiscal year ended December 31, 2024, relating to the Acquired Fund and the Acquiring Fund.](http://www.sec.gov/Archives/edgar/data/756913/000168386325001776/f41004d1.htm)

[Unaudited Financial Statements of JHVIT for the semiannual period ended June 30, 2025, relating to the Acquired Fund and the Acquiring Fund.](http://www.sec.gov/Archives/edgar/data/756913/000168386325007147/f42696d1.htm)

*Pro forma* Financial Information for the Reorganization.

**INFORMATION INCORPORATED BY REFERENCE** 

This Statement of Additional Information incorporates by reference the following documents (or designated portions thereof) as filed with the Securities and Exchange Commission ("SEC") (File Nos. 2-94157; 811-04146):

1. [The Statement of Additional Information of JHVIT dated April 28, 2025, as supplemented, relating to the Acquired Fund and the Acquiring Fund.](http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/756913/000119312525082716/d891604d485bpos.htm)

------

##### [**Table of Contents**](#toc)
2. [The Audited Financial Statements of JHVIT for the fiscal year ended December 31, 2024, relating to the Acquired Fund and the Acquiring Fund, including the report thereon of PricewaterhouseCoopers LLP, independent registered public accounting firm, are incorporated by reference to JHVIT's Annual Report to Shareholders dated December 31, 2024 filed with the SEC on Form N-CSR on March 6, 2025, insofar as such financial statements and report relate to the Acquired Fund and the Acquiring Fund.](http://www.sec.gov/Archives/edgar/data/756913/000168386325001776/f41004d1.htm)

3. [The Unaudited Financial Statements of JHVIT for the semiannual period ended June 30, 2025, relating to the Acquired Fund and the Acquiring Fund, are incorporated by reference to JHVIT's Semiannual Report to Shareholders dated June 30, 2025 filed with the SEC on Form N-CSR on August 29, 2025, insofar as such financial statements and report relate to the Acquired Fund and the Acquiring Funds.](http://www.sec.gov/Archives/edgar/data/756913/000168386325007147/f42696d1.htm)

------

##### [**Table of Contents**](#toc)
**PRO FORMA FINANCIAL INFORMATION** 

<u>Combination of American International Trust into Disciplined Value International Trust</u>

The unaudited pro forma information provided herein should be read in conjunction with the audited Annual Report to Shareholders of American International Trust and Disciplined Value International Trust for the period ended December 31, 2024, which is on file with the SEC and available at no charge.

The unaudited pro forma information set forth below for the period ended June 30, 2025 is intended to present ratios and supplemental data as if the merger of American International Trust, or Acquired Fund, into Disciplined Value International Trust, or Acquiring Fund (collectively, the "Funds"), had been consummated at June 30, 2025. The merger is intended to consolidate the Acquired and Acquiring Fund, each of which invests in international equity securities.

The Funds have the same administrator, fund recordkeeping services agent, fund accounting agents and custodian. Each of such service providers has entered into an agreement with the Trust that governs the provision of services to the Funds. Such agreements contain the same terms. The Acquired Fund and Acquiring Fund had effective advisory fee rates of 0.00% and 0.68%, respectively, for the 12-month period ended June 30, 2025.

As of June 30, 2025, the net assets of: (i) the Acquired Fund were $369,841,203; and (ii) the Acquiring Fund were $302,471,391. The net assets of the combined fund as of June 30, 2025 would have been $672,113,821.00, reflecting a reduction of $$198,773 due to estimated reorganization costs (legal, accounting, printing, solicitation and tabulation of proxies, and portfolio trading costs).

On a pro forma basis, for the 12-month period ended June 30, 2025, this proposed reorganization would result in an estimated $649,347 increase in the combined management fees charged, an estimated $1,873,070 decrease in 12b-1 fees, and an estimated $41,353 decrease in combined other operating expenses (including audit fees) due to the combined fund eliminating duplicative expenses and achieving other operating economies of scale, resulting in a less than $0.01 per share expense decrease.

No significant accounting policies will change as a result of the proposed reorganization, specifically, policies regarding valuation or Subchapter M income tax compliance. The Acquiring Fund will be the accounting survivor of the proposed reorganization and will also maintain the performance history of the Acquiring Fund at the closing of the proposed reorganization.

As of December 31, 2024, American International Trust had long-term capital loss carryforwards of $3,240,785, which do not expire.

The estimated reorganization costs of $198,773 incurred in connection with entering into and carrying out the provisions of the Agreement and Plan of Reorganization will be borne pro rata by the Acquired Fund and Acquiring Fund on the basis of expense ratio savings within the combined fund. The projected expenses of the Reorganization (consisting of legal, accounting, printing, and solicitation and proxy tabulation costs) are $198,773, of which $182,626 will be borne by the Acquired Fund (amounting to four basis points and less than $0.01 per share) and $16,147 will be borne by the Acquiring Fund (amounting to less than one basis point and less than $0.01 per share). If the Reorganization is not consummated, these expenses will be paid by JHVTA. Transaction costs are not anticipated to be material in amount and are estimated to not exceed $10,000, which is less than $0.01 per share.

------

##### [**Table of Contents**](#toc)
**Part C** <br>**Other Information**

**Item 15. Indemnification**

No change from the information set forth in Item 30 of the most recently filed [amendment to the Registration Statement of John](https://www.sec.gov/ix?doc=/Archives/edgar/data/756913/000119312525082716/d891604d485bpos.htm)[Hancock Variable Insurance Trust (the "Registrant") on Form N-1A under the Securities Act of 1933, as amended (the "1933 Act"), and](https://www.sec.gov/ix?doc=/Archives/edgar/data/756913/000119312525082716/d891604d485bpos.htm)[the Investment Company Act of 1940, as amended (File Nos. 2-94157 and 811-04146) as filed with the Securities and Exchange](https://www.sec.gov/ix?doc=/Archives/edgar/data/756913/000119312525082716/d891604d485bpos.htm)[Commission (the "SEC") on April 16, 2025 (accession number 0001193125-25-082716)](https://www.sec.gov/ix?doc=/Archives/edgar/data/756913/000119312525082716/d891604d485bpos.htm), which information is incorporated herein by reference.

**Item 16. Exhibits** 

---

| | |
|:---|:---|
| 1(a) | &nbsp;&nbsp; Amended and Restated Declaration of Trust dated January 22, 2016, as amended – [<u>previously filed as exhibit (a)(44)(A) to</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322816009262/e437643_ex99-a44a.htm)<br> [<u>post-effective amendment no. 113 filed on April 27, 2016, accession number 0001133228-16-009262.</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322816009262/e437643_ex99-a44a.htm)<br>|
| 1(a)(1) | &nbsp;&nbsp; Amendment to Declaration of Trust dated December 13, 2018 – [<u>previously filed as exhibit (a)(44)(B) to post-effective</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322819002411/jhvit-html1026_ex99a44b.htm)<br> [<u>amendment no. 119 filed on April 25, 2019, accession number 0001133228-19-002411.</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322819002411/jhvit-html1026_ex99a44b.htm)<br>|
| 1(a)(2) | &nbsp;&nbsp; Amendment to Declaration of Trust dated September 25, 2024 – [<u>previously filed as exhibit (a)(2) to post-effective</u>](https://www.sec.gov/Archives/edgar/data/756913/000119312525082716/d891604dex99a2.htm)<br> [<u>amendment no. 127 filed on April 28, 2025, accession number 0001193125-25-082716.</u>](https://www.sec.gov/Archives/edgar/data/756913/000119312525082716/d891604dex99a2.htm)<br>|
| 2(a) | &nbsp;&nbsp; Revised By-laws of the Trust dated June 30, 2006 – [<u>previously filed as exhibit (b)(2) to post-effective amendment no. 72</u>](https://www.sec.gov/Archives/edgar/data/756913/000095013507000767/b63596mrexv99wxbyx2y.txt)<br> [<u>filed on February 13, 2007, accession number 0000950135-07-000767.</u>](https://www.sec.gov/Archives/edgar/data/756913/000095013507000767/b63596mrexv99wxbyx2y.txt).<br>|
| 2(a)(1) | &nbsp;&nbsp; Amendment dated December 13, 2006 to the By-laws of the Trust, dated June 30, 2006 – [<u>previously filed as exhibit (b)(3)</u>](https://www.sec.gov/Archives/edgar/data/756913/000095013507000767/b63596mrexv99wxbyx3y.txt)<br> [<u>to post-effective amendment no. 72 filed on February 13, 2007, accession number 0000950135-07-000767.</u>](https://www.sec.gov/Archives/edgar/data/756913/000095013507000767/b63596mrexv99wxbyx3y.txt)<br>|
| 2(a)(2) | &nbsp;&nbsp; Amendment dated March 10, 2016 to the By-laws of the Trust, dated June 30, 2006 – [<u>previously filed as exhibit (b)(2) to</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322816009262/e437643_ex99-b2.htm)<br> [<u>post-effective amendment no. 113 filed on April 27, 2016, accession number 0001133228-16-009262.</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322816009262/e437643_ex99-b2.htm)<br>|
| 3 | Not applicable. |
| 4 | Form of Agreement and Plan of Reorganization **(filed herewith as Appendix A to the Proxy Statement/Prospectus)**. |
| 5 | &nbsp;&nbsp; Specimen Share Certificate – [<u>previously filed as exhibit (4) to post-effective amendment no. 38 filed September 17, 1997,</u>](https://www.sec.gov/Archives/edgar/data/756913/0000950135-97-003874.txt)<br> [<u>accession number 0000950135-97-003874</u>](https://www.sec.gov/Archives/edgar/data/756913/0000950135-97-003874.txt).<br>|
| 6(a) | &nbsp;&nbsp; Amended and Restated Advisory Agreement dated June 30, 2020 between John Hancock Variable Insurance Trust (the <br> "Registrant") and John Hancock Variable Trust Advisers LLC<sup>1</sup> (the "Adviser") – [<u>previously filed as exhibit (d) to post-effective</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322821002276/jhvit-html3521_ex99d.htm)<br> [<u>amendment no. 123 filed on April 23, 2021, accession number 0001133228-21-002276.</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322821002276/jhvit-html3521_ex99d.htm)<br>|
| 6(a)(1) | &nbsp;&nbsp; Amendment dated June 24, 2021 to Amended and Restated Advisory Agreement dated June 30, 2020 relating to Global <br> Equity Trust and Disciplined Value International Trust, between the Registrant and the Adviser – [<u>previously filed as exhibit</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322822002304/jhvit-html4616_ex99d4.htm)<br> [<u>(d)(4) to post-effective amendment no. 124 filed on April 22, 2022, accession number 0001133228-22-002304.</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322822002304/jhvit-html4616_ex99d4.htm)<br>|
| 6(a)(2) | &nbsp;&nbsp; Amendment dated March 24, 2022 to Amended and Restated Advisory Agreement dated June 30, 2020 relating to Health <br> Sciences Trust, Mid Value Trust, International Small Company Trust, Disciplined Value Emerging Markets Equity Trust and <br> Disciplined Value International Trust, between the Registrant and the Adviser – [<u>previously filed as exhibit (d)(6) to</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322822002304/jhvit-html4616_ex99d6.htm)<br> [<u>post-effective amendment no. 124 filed on April 22, 2022, accession number 0001133228-22-002304.</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322822002304/jhvit-html4616_ex99d6.htm)<br>|
| 6(a)(3) | &nbsp;&nbsp; Amendment dated March 30, 2023 to Amended and Restated Advisory Agreement dated June 30, 2020 relating to <br> Disciplined Value International Trust between the Registrant and the Adviser – previously filed as exhibit (d)(8) to <br> post-effective amendment no. 125 filed on April 21, 2023, [<u>accession number 0001133228-23-002481</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322823002481/jhvit-html6140_ex99d8.htm).<br>|
| 6(a)(4) | &nbsp;&nbsp; Amendment dated June 29, 2023 to Amended and Restated Advisory Agreement dated June 30, 2020 relating to Blue <br> Chip Growth Trust and Disciplined Value International Trust between the Registrant and the Adviser – [<u>previously filed as</u>](https://www.sec.gov/Archives/edgar/data/756913/000119312524099023/d649461dex99d9.htm)<br> [<u>exhibit (d)(9) on April 17, 2024, accession number 0001193125-24-099023.</u>](https://www.sec.gov/Archives/edgar/data/756913/000119312524099023/d649461dex99d9.htm)<br>|
| 6(a)(5) | &nbsp;&nbsp; Amendment dated December 12, 2024 to Amended and Restated Advisory Agreement dated June 30, 2020 relating to <br> Disciplined Value International Trust and Health Sciences Trust between the Registrant and the Adviser – [<u>previously filed as</u>](https://www.sec.gov/Archives/edgar/data/756913/000119312525082716/d891604dex99d12.htm)<br> [<u>exhibit (d)(12) to post-effective amendment no. 127 filed on April 28, 2025, accession number</u>](https://www.sec.gov/Archives/edgar/data/756913/000119312525082716/d891604dex99d12.htm)<br> [<u>0001193125-25-082716</u>](https://www.sec.gov/Archives/edgar/data/756913/000119312525082716/d891604dex99d12.htm).<br>|

---

**C-1**

------

---

| | |
|:---|:---|
| 6(b) | &nbsp;&nbsp; Subadvisory Agreement dated February 12, 2020 relating to Disciplined Value International Trust, between the Adviser and <br> Boston Partners Global Investors, Inc. – [<u>previously filed as exhibit (d)(2)(B) to post-effective amendment no. 121 filed on</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322820001889/jhvit-html2203_ex99d2b.htm)<br> [<u>April 24, 2020, accession number 0001133228-20-001889.</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322820001889/jhvit-html2203_ex99d2b.htm)<br>|
| 6(b)(1) | &nbsp;&nbsp; Amendment dated June 24, 2021 to Subadvisory Agreement dated February 12, 2020 relating to Disciplined Value <br> International Trust, between the Adviser and Boston Partners Global Investors, Inc. – [<u>previously filed as exhibit (d)(12) to</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322822002304/jhvit-html4616_ex99d12.htm)<br> [<u>post-effective amendment no. 124 filed on April 22, 2022, accession number 0001133228-22-002304.</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322822002304/jhvit-html4616_ex99d12.htm)<br>|
| 6(b)(2) | &nbsp;&nbsp; Amendment dated March 24, 2022 to Subadvisory Agreement dated February 12, 2020 relating to Disciplined Value <br> International Trust, between the Adviser and Boston Partners Global Investors, Inc. – [<u>previously filed as exhibit (d)(13) to</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322822002304/jhvit-html4616_ex99d13.htm)<br> [<u>post-effective amendment no. 124 filed on April 22, 2022, accession number 0001133228-22-002304.</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322822002304/jhvit-html4616_ex99d13.htm)<br>|
| 6(b)(3) | &nbsp;&nbsp; Amendment dated March 30, 2023 to Subadvisory Agreement dated February 12, 2020 relating to Disciplined Value <br> International Trust, between the Adviser and Boston Partners Global Investors, Inc. – [<u>previously filed as exhibit (d)(13) to</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322823002481/jhvit-html6140_ex99d13.htm)<br> [<u>post-effective amendment no. 125 filed on April 21, 2023, accession number 0001133228-23-002481</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322823002481/jhvit-html6140_ex99d13.htm).<br>|
| 6(b)(4) | &nbsp;&nbsp; Amendment dated June 29, 2023 to Subadvisory Agreement dated February 12, 2020 relating to Disciplined Value <br> International Trust, between the Adviser and Boston Partners Global Investors, Inc. – [<u>previously filed as exhibit (d)(16) on</u>](https://www.sec.gov/Archives/edgar/data/756913/000119312524099023/d649461dex99d16.htm)<br> [<u>April 17, 2024, accession number 0001193125-24-099023.</u>](https://www.sec.gov/Archives/edgar/data/756913/000119312524099023/d649461dex99d16.htm)<br>|
| 6(b)(5) | &nbsp;&nbsp; Amendment dated December 12, 2024 to Subadvisory Agreement dated February 12, 2020 relating to Disciplined Value <br> International Trust, between the Adviser and Boston Partners Global Investors, Inc. – [<u>previously filed as exhibit (d)(22) to</u>](https://www.sec.gov/Archives/edgar/data/756913/000119312525082716/d891604dex99d22.htm)<br> [<u>post-effective amendment no. 127 filed on April 28, 2025, accession number 0001193125-25-082716</u>](https://www.sec.gov/Archives/edgar/data/756913/000119312525082716/d891604dex99d22.htm).<br>|
| 7 | &nbsp;&nbsp; Amended and Restated Distribution Agreement dated June 30, 2020 between the Registrant and John Hancock <br> Distributors, LLC (the "Distributor") – [<u>previously filed as exhibit (e) to post-effective amendment no. 123 filed on April 23,</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322821002276/jhvit-html3521_ex99e.htm)<br> [<u>2021, accession number 0001133228-21-002276.</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322821002276/jhvit-html3521_ex99e.htm)<br>|
| 8 | Not Applicable. |
| 9(a) | &nbsp;&nbsp; Custodian Agreement dated September 26, 2008 between the Trust and State Street Bank and Trust Company – [<u>previously</u>](https://www.sec.gov/Archives/edgar/data/756913/000095013509000965/b73715a1exv99wxgy.htm)<br> [<u>filed as exhibit (g) to post-effective amendment no. 84 filed on February 13, 2009, accession number</u>](https://www.sec.gov/Archives/edgar/data/756913/000095013509000965/b73715a1exv99wxgy.htm)<br> [<u>0000950135-09-000965.</u>](https://www.sec.gov/Archives/edgar/data/756913/000095013509000965/b73715a1exv99wxgy.htm)<br>|
| 9(a)(1) | &nbsp;&nbsp; Amendment dated October 1, 2015 to Custodian Agreement dated September 26, 2008 between the Trust and State <br> Street Bank and Trust Company – [<u>previously filed as exhibit (g)(1) to post-effective amendment no. 123 filed on April 23,</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322821002276/jhvit-html3521_ex99g1.htm)<br> [<u>2021, accession number 0001133228-21-002276.</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322821002276/jhvit-html3521_ex99g1.htm)<br>|
| 9(a)(2) | &nbsp;&nbsp; Amendment dated December 14, 2020 to Custodian Agreement dated September 26, 2008 between the Trust and State <br> Street Bank and Trust Company – [<u>previously filed as exhibit (g)(2) to post-effective amendment no. 123 filed on April 23,</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322821002276/jhvit-html3521_ex99g2.htm)<br> [<u>2021, accession number 0001133228-21-002276.</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322821002276/jhvit-html3521_ex99g2.htm)<br>|
| 9(a)(3) | &nbsp;&nbsp; Amendment dated July 1, 2022 to Custodian Agreement dated September 26, 2008 between the Trust and State Street <br> Bank and Trust Company – [<u>previously filed as exhibit (g)(3) to post-effective amendment no. 125 filed on April 21, 2023,</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322823002481/jhvit-html6140_ex99g3.htm)<br> [<u>accession number 0001133228-23-002481.</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322823002481/jhvit-html6140_ex99g3.htm)<br>|
| 10(a) | &nbsp;&nbsp; Series I Shares Rule 12b-1 Plan (formerly Class A Shares) dated September 21, 2001, as amended April 4, 2002, June 26, <br> 2003, April 1, 2004, December 13, 2004, June 23, 2005, September 23, 2005, December 13, 2005, March 30, 2006, <br> March 23, 2007, September 28, 2007, June 27, 2008, September 26, 2008, December 17, 2008, March 20, 2009, <br> June 25, 2010, March 25, 2011, March 23, 2012, June 30, 2012 and September 27, 2013 – [<u>previously filed as exhibit</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322815001781/e407645_ex99-m.htm)<br> [<u>(m) on April 24, 2015, accession number 0001133228-15-001781.</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322815001781/e407645_ex99-m.htm)<br>|
| 10(a)(1) | &nbsp;&nbsp; Series II Shares Rule 12b-1 Plan (formerly Class B Shares) dated September 21, 2001, as amended April 4, 2002, April 2, <br> 2003, April 1, 2004, December 13, 2004, June 23, 2005, September 23, 2005, December 13, 2005, March 30, 2006, <br> March 23, 2007, September 28, 2007; June 27, 2008, September 26, 2008, December 17, 2008, March 20, 2009; <br> June 25, 2010, March 25, 2011, March 23, 2012, June 30, 2012 and September 27, 2013 – [<u>previously filed as exhibit</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322815001781/e407645_ex99-m1.htm)<br> [<u>(m)(1) on April 24, 2015, accession number 0001133228-15-001781.</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322815001781/e407645_ex99-m1.htm)<br>|
| 10(a)(2) | &nbsp;&nbsp; Series II Shares Voluntary Rule 12b-1 Fee Waivers dated July 1, 2016 for American Growth Trust, American Growth and <br> Income Trust, American International Trust, American Asset Allocation Trust, American New World Trust, and American <br> Global Growth Trust – [<u>previously filed as exhibit (m)(1)(A) on April 26, 2018, accession number 0001133228-18-002473.</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322818002473/e490940_ex99-m1a.htm)<br>|

---

**C-2**

------

---

| | |
|:---|:---|
| 10(a)(3) | &nbsp;&nbsp; Series III Shares Rule 12b-1 Plan dated March 23, 2007, as amended September 28, 2007, March 20, 2009, June 25, <br> 2010, March 25, 2011, March 23, 2012 and September 27, 2013 – [<u>previously filed as exhibit (m)(2) on April 24, 2015,</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322815001781/e407645_ex99-m2.htm)<br> [<u>accession number 0001133228-15-001781.</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322815001781/e407645_ex99-m2.htm)<br>|
| 10(b) | &nbsp;&nbsp; Rule 18f-3 Plan dated September 21, 2001, as amended April 4, 2002, June 26, 2003, December 13, 2004, June 23, <br> 2005, December 13, 2005, March 30, 2006, March 23, 2007, September 28, 2007, March 25, 2008, March 23, 2012, <br> June 30, 2013 and September 27, 2013 – [<u>previously filed as exhibit (n) on April 24, 2015, accession number</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322815001781/e407645_ex99-n.htm)<br> [<u>0001133228-15-001781.</u>](https://www.sec.gov/Archives/edgar/data/756913/000113322815001781/e407645_ex99-n.htm)<br>|
| 10(c) | &nbsp;&nbsp; Agreement to Waive Advisory Fees and Reimburse Expenses dated October 9, 2024 between the Registrant and John <br> Hancock Variable Trust Advisers LLC – [<u>previously filed as exhibit (h)(8) to post-effective amendment no. 127 filed on</u>](https://www.sec.gov/Archives/edgar/data/756913/000119312525082716/d891604dex99h8.htm)<br> [<u>April 28, 2025, accession number 0001193125-25-082716</u>](https://www.sec.gov/Archives/edgar/data/756913/000119312525082716/d891604dex99h8.htm).<br>|
| 10(d) | &nbsp;&nbsp; Advisory Fee Waiver Agreement dated December 12, 2024 between the Registrant and John Hancock Variable Trust <br> Advisers LLC – [<u>previously filed as exhibit (h)(9) to post-effective amendment no. 127 filed on April 28, 2025, accession</u>](https://www.sec.gov/Archives/edgar/data/756913/000119312525082716/d891604dex99h9.htm)<br> [<u>number 0001193125-25-082716</u>](https://www.sec.gov/Archives/edgar/data/756913/000119312525082716/d891604dex99h9.htm).<br>|
| 11 | &nbsp;&nbsp; Opinion and Consent of Harsha Pulluru, Esq., regarding legality of issuance of shares and other matters. – [**<u>FILED</u>**](d924532dex9911.htm)<br> [**<u>HEREWITH</u>**](d924532dex9911.htm).<br>|
| 12 | Form of Opinion of K&L Gates LLP on tax matters. – [**<u>FILED HEREWITH</u>**](d924532dex9912.htm). |
| 13 | Not applicable. |
| 14 | Consent of PricewaterhouseCoopersLLP. – [**<u>FILED HEREWITH</u>**](d924532dex9914.htm). |
| 15 | Not Applicable. |
| 16 | Power of Attorney dated December 11, 2025. – [**<u>FILED HEREWITH</u>**](d924532dex9916.htm). |

---

**1**

Prior to June 28, 2019, John Hancock Variable Trust Advisers LLC was known as John Hancock Investment Management Services, LLC.

**2**

Prior to May 7, 2019, Manulife Investment Management (US) LLC was known as John Hancock Asset Management a division of Manulife Asset Management (US) LLC (formerly known as Sovereign Asset Management, LLC).

**3**

Prior to May 7, 2019, Manulife Investment Management (North America) Limited was known as John Hancock Asset Management a division of Manulife Asset Management (North America) Limited.

**Item 17. Undertakings**

(1) The undersigned Registrant agrees that prior to any public reoffering of the securities registered through the use of a prospectus which is a part of this Registration Statement by any person or party who is deemed to be an underwriter within the meaning of Rule 145(c) of the Securities Act of 1933, the reoffering prospectus will contain the information called for by the applicable registration form for reofferings by persons who may be deemed underwriters, in addition to the information called for by the other items of the applicable form.

(2) The undersigned Registrant agrees that every prospectus that is filed under paragraph (1) above will be filed as part of an amendment to the Registration Statement and will not be used until the amendment is effective, and that, in determining any liability under the Securities Act of 1933, each post-effective amendment shall be deemed to be a new registration statement for the securities offered therein, and the offering of the securities at that time shall be deemed to be the initial bona fide offering of them.

(3) The undersigned Registrant agrees that it shall file a final executed version of the legal opinion as to tax matters as an exhibit to the subsequent post-effective amendment to its Registration Statement on Form N-14 filed with the SEC upon the closing of the reorganization contemplated by this Registration Statement on Form N-14.

**C-3**

------

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, as amended (the "1933 Act") the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, duly authorized, in the City of Boston and The Commonwealth of Massachusetts, on the 14<sup>th</sup> day of January, 2026.

---

| | |
|:---|:---|
| **JOHN HANCOCK VARIABLE INSURANCE TRUST** | **JOHN HANCOCK VARIABLE INSURANCE TRUST** |
| By: | /s/ Kristie M. Feinberg |
|  | Name: Kristie M. Feinberg<br> Title: President (Chief Executive Officer and Principal <br> Executive Officer) and Trustee<br>|

---

Pursuant to the requirements of the 1933 Act, this Registration Statement has been signed below by the following persons in the capacities and on the date(s) indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ Kristie M. Feinberg | President<br> (Chief Executive Officer and Principal Executive Officer) and Trustee | January 14, 2026 |
| Kristie M. Feinberg | President<br> (Chief Executive Officer and Principal Executive Officer) and Trustee | January 14, 2026 |
| /s/ Fernando A. Silva | Chief Financial Officer<br> (Principal Financial Officer and Principal Accounting Officer) | January 14, 2026 |
| Fernando A. Silva | Chief Financial Officer<br> (Principal Financial Officer and Principal Accounting Officer) | January 14, 2026 |
| /s/ Andrew G. Arnott\* | Trustee | January 14, 2026 |
| Andrew G. Arnott | Trustee | January 14, 2026 |
| /s/ William K. Bacic\* | Trustee | January 14, 2026 |
| William K. Bacic | Trustee | January 14, 2026 |
| /s/ James R. Boyle\* | Trustee | January 14, 2026 |
| James R. Boyle | Trustee | January 14, 2026 |
| /s/ Noni Ellison McKee\* | Trustee | January 14, 2026 |
| Noni Ellison McKee | Trustee | January 14, 2026 |
| /s/ Grace K. Fey\* | Trustee | January 14, 2026 |
| Grace K. Fey | Trustee | January 14, 2026 |
| /s/ Dean C. Garfield\* | Trustee | January 14, 2026 |
| Dean C. Garfield | Trustee | January 14, 2026 |
| /s/ Christine L. Hurtsellers\* | Trustee | January 14, 2026 |
| Christine L. Hurtsellers | Trustee | January 14, 2026 |
| /s/ Deborah C. Jackson\* | Trustee | January 14, 2026 |
| Deborah C. Jackson | Trustee | January 14, 2026 |
| /s/ Hassell H. McClellan\* | Trustee | January 14, 2026 |
| Hassell H. McClellan | Trustee | January 14, 2026 |
| /s/ Kenneth J. Phelan\* | Trustee | January 14, 2026 |
| Kenneth J. Phelan | Trustee | January 14, 2026 |
| /s/ Frances G. Rathke\* | Trustee | January 14, 2026 |
| Frances G. Rathke | Trustee | January 14, 2026 |
| /s/ Thomas R. Wright\* | Trustee | January 14, 2026 |
| Thomas R. Wright | Trustee | January 14, 2026 |

---

**\***

By: Power of Attorney.

**C-4**

------

---

| | |
|:---|:---|
| By: | /s/ Harsha Pulluru |
|  | Harsha Pulluru<br> Attorney-In-Fact<br>|

---

**\***

Pursuant to Power of Attorney filed herewith.

**C-5**

------

**Exhibit Index** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Form of Agreement and Plan of Reorganization (filed herewith as Exhibit A to
the Proxy Statement/Prospectus)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(11) [<u>Opinion and Consent of Harsha Pulluru, Esq., regarding legality of issuance of shares and other matters</u>](d924532dex9911.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(12) [<u>Form of Opinion of K&L Gates LLP on tax matters</u>](d924532dex9912.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(14) [<u>Consent of PricewaterhouseCoopers LLP</u>](d924532dex9914.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(16) [<u>Power of Attorney dated December 11, 2025</u>](d924532dex9916.htm)

**C-6**

------

## Exhibit 99.11

***Exhibit 11*** 

John Hancock Variable Insurance Trust

200 Berkeley Street

Boston, MA 02116

January 14, 2026

To Whom It May Concern:

This opinion is written in reference to the shares of beneficial interest, $0.01 par value (the "Shares"), of Disciplined Value International Trust, a series of John Hancock Variable Insurance Trust, a Massachusetts business trust (the "Trust"), to be offered and sold pursuant to the Trust's Registration Statement on Form N-14 (the "Registration Statement") filed with the Securities and Exchange Commission (the "Commission") pursuant to the Securities Act of 1933 on or about January 14, 2026.

I have examined such records and documents and reviewed such questions of law as I deemed necessary for purposes of this opinion.

1. The Trust has been duly recorded under the laws of the Commonwealth of Massachusetts and is a validly existing Massachusetts business trust.

2. The Shares have been duly authorized and, when sold in the manner contemplated by the Registration Statement, will be legally issued.

3. Purchasers of the Shares will not have any obligation to make payments to the Trust or its creditors (other than the purchase price of the Shares) or contributions to the Trust or its creditors solely by reason of the purchasers' ownership of the Shares.

The Trust is an entity commonly known as a Massachusetts business trust. The opinion above, as it relates to purchasers' obligations to make payments or contributions to the Trust or its creditors, is, therefore, qualified to the extent that under Massachusetts law, shareholders of a Massachusetts business trust may be held personally liable for the obligations of the trust.

I consent to the filing of this opinion with the Commission as an exhibit to the Registration Statement and to the reference made to me in the Registration Statement and any amendments thereto.

---

| |
|:---|
| Very truly yours, |
| /s/ Harsha Pulluru |
| Harsha Pulluru |
| Assistant Secretary, John Hancock Variable Insurance Trust |

---

## Exhibit 99.12

***Exhibit 12***![LOGO](g924532g0109031211632.jpg)

[ ], 2026

American International Trust

a series of John Hancock Variable Insurance Trust

200 Berkeley Street

Boston, MA 02116

Disciplined Value International Trust

a series of John Hancock Variable Insurance Trust

200 Berkeley Street

Boston, MA 02116

John Hancock Life Insurance Company (U.S.A.)

200 Berkeley Street

Boston, MA 02116

John Hancock Life Insurance Company of New York

200 Berkeley Street

Boston, MA 02116

Re: <u>Reorganization to Combine Series of a Massachusetts Business Trust</u>

Ladies and Gentlemen:

You have requested our opinion regarding certain federal income tax consequences to the holders ("Contract Owners") of certain variable annuity contracts and variable life insurance policies (collectively, the "Contracts") that are issued or administered by John Hancock Life Insurance Company (U.S.A.) ("John Hancock USA") or by John Hancock Life Insurance Company of New York ("John Hancock NY") and funded by separate accounts of John Hancock USA or John Hancock NY for which American International Trust ("Acquired Fund"), a separate series of John Hancock Variable Insurance Trust, a Massachusetts business trust ("JHVIT"), and Disciplined Value International Trust (the "Acquiring Fund"), also a separate series of JHVIT, serve as underlying investment vehicles.

Pursuant to the Agreement and Plan of Reorganization (the "Plan") dated as of [ ], 2026, executed by JHVIT on behalf of the Acquired Fund and Acquiring Fund, Acquired Fund will transfer all of its assets to Acquiring Fund in exchange solely for voting shares of beneficial interest of Acquiring Fund ("Acquiring Fund Shares") and the assumption by Acquiring Fund of all of the liabilities of Acquired Fund and the distribution of the Acquiring Fund Shares to the shareholders of Acquired Fund in complete liquidation of Acquired Fund (the "Reorganization").

For purposes of this opinion, we have examined and rely upon (1) the Plan, (2) the Proxy Statement/Prospectus dated February [18], 2026, (3) the facts and representations contained in the letter dated as of this date, addressed to us from John Hancock USA and John Hancock NY, and (4) such other documents and instruments as we have deemed necessary or appropriate for purposes of rendering this opinion.

For purposes of this opinion, we are assuming that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) each of the Contracts is and, at the time of the Reorganization, will be treated as a "variable contract" within the meaning of Section 817(d) of the Internal Revenue Code of 1986, as amended (the "Code");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) the ownership of shares in Acquired Fund and Acquiring Fund, and access to such Funds, satisfies the requirements and limitations set forth in Treas. Reg. Section 1.817-5(f); and

------

[ ], 2026

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) under the so-called investor control rules, either John Hancock USA or John Hancock NY, and not the Contract Owners, have been and are treated for federal income tax purposes as the owners of the interests in Acquired Fund and Acquiring Fund that underlie the Contracts.

This opinion is based upon the Code, United States Treasury regulations, judicial decisions and administrative rulings and pronouncements of the Internal Revenue Service, all as in effect on the date hereof. This opinion is conditioned upon (a) the Reorganization taking place in the manner described in the Plan, (b) the information provided in the Proxy Statement/Prospectus referred to above, and (c) the facts and representations contained in the letter dated as of this date, addressed to us from John Hancock USA and John Hancock NY, and also the above assumptions, being true and accurate as of the closing date of the Reorganization.

Based upon the foregoing, it is our opinion that, for federal income tax purposes, the Contract Owners will not recognize any taxable income, gains or losses as a result of the Reorganization.

We express no opinion as to the federal income tax consequences of the Reorganization except as expressly set forth above, or as to any transaction except those consummated in accordance with the Plan and the representations made to us. Our opinion addresses only the specific federal income tax consequences of the Reorganization set forth above and does not address any other federal, or any state, local, or foreign tax consequences of the Reorganization or any other action (including any taken in connection therewith). Finally, our opinion is solely for the information and use of the addressees and the Contract Owners and may not be relied on for any purpose by any other person without our express written consent.

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement on Form N-14 of the JHVIT (the "Registration Statement") filed with the U.S. Securities and Exchange Commission (the "Commission") in connection with the Reorganization. Further, we hereby consent to the references to our firm and the discussion of this opinion in the Registration Statement under the Prospectus heading "Federal Income Tax Consequences." In giving this consent, we do not thereby admit that we are experts with respect to any part of the Registration Statement within the meaning of the term "expert" as used in Section 11 of the Securities Act of 1933, as amended (the "Securities Act") or the rules and regulations promulgated thereunder by the Commission, nor do we admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.

Very truly yours,

## Exhibit 99.14

***Exhibit 14***

<u>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</u> 

We hereby consent to the incorporation by reference in this Registration Statement on Form N-14 of John Hancock Variable Insurance Trust of our reports dated February 24, 2025, relating to the financial statements and financial highlights of American International Trust and Disciplined Value International Trust, which appear in John Hancock Variable Insurance Trust's Certified Shareholder Report on Form N-CSR for the year ended December 31, 2024. We also consent to the references to us under the headings "Financial Statements; Experts", "Appendix B Financial Highlights of the Funds" and "Statement of Additional Information" in such Registration Statement.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

January 14, 2026

## Exhibit 99.16

***Exhibit 16*** 

**John Hancock Variable Insurance Trust** 

**POWER OF ATTORNEY** 

I do hereby constitute and appoint Thomas Dee, Khimmara Greer, Kinga Kapuscinski, Nicholas J. Kolokithas, Mara C.S. Moldwin, Harsha Pulluru, Christopher Sechler, Betsy Anne Seel and Steven Sunnerberg, or any one of them, my true and lawful attorneys to execute a registration statement, and any amendments thereto, to be filed with the Securities and Exchange Commission ("<u>SEC</u><u>"</u>) under the Securities Act of 1933, as amended (the "<u>1933 Act</u><u>"</u>) and/or the Investment Company Act of 1940, as amended (the "<u>1940 Act</u><u>"</u>), and to do any and all acts and things and to execute any and all instruments for me and in my name in the capacities indicated below, which said attorneys, or any of them, may deem necessary or advisable to enable John Hancock Investment Trust (the "<u>Trust</u><u>"</u>), to comply with the 1933 Act and the 1940 Act, and any rules, regulations and requirements of the SEC, in connection with such registration statement, including specifically, but without limitation, power and authority to sign for me in the capacity indicated below, the Trust's registration statement on Form N-14 relating to the fund combination listed below and any amendments (including post-effective amendments) thereto; and I do hereby ratify and confirm all that the said attorneys, or any of them, shall do or cause to be done by virtue of this power of attorney.

**<u>Fund Combination</u>**

American International Trust, a series of John Variable Insurance Trust

into

Disciplined Value International Trust, a series of John Hancock Variable Insurance Trust

*(THE REMAINDER OF THIS SPACE HAS BEEN INTENTIONALLY LEFT BLANK)* 

------

Dated: December 11, 2025.

---

| | | |
|:---|:---|:---|
| **Name** | **Signature** | **Title** |
| Kristie M. Feinberg | /s/ Kristie M. Feinberg | President and Trustee |
| Fernando A. Silva | /s/ Fernando A. Silva | Chief Financial Officer<br> (Principal Financial Officer and Principal Accounting Officer) |
| Andrew G. Arnott | /s/ Andrew G. Arnott | Trustee |
| William K. Bacic | /s/ William K. Bacic | Trustee |
| James R. Boyle | /s/ James R. Boyle | Trustee |
| William H. Cunningham | /s/ William H. Cunningham | Trustee |
| Noni Ellison McKee | /s/ Noni Ellison McKee | Trustee |
| Grace K. Fey | /s/ Grace K. Fey | Trustee |
| Dean C. Garfield | /s/ Dean C. Garfield | Trustee |
| Christine L. Hurtsellers | /s/ Christine L. Hurtsellers | Trustee |
| Deborah C. Jackson | /s/ Deborah C. Jackson | Trustee |
| Hassell H. McClellan | /s/ Hassell H. McClellan | Trustee |
| Kenneth J. Phelan | /s/ Kenneth J. Phelan | Trustee |
| Frances G. Rathke | /s/ Frances G. Rathke | Trustee |
| Thomas R. Wright | /s Thomas R. Wright | Trustee |

---